JPH0873390A - Calcitriol intermediate and its production - Google Patents
Calcitriol intermediate and its productionInfo
- Publication number
- JPH0873390A JPH0873390A JP21394494A JP21394494A JPH0873390A JP H0873390 A JPH0873390 A JP H0873390A JP 21394494 A JP21394494 A JP 21394494A JP 21394494 A JP21394494 A JP 21394494A JP H0873390 A JPH0873390 A JP H0873390A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- ether
- solution
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 8
- GMRQFYUYWCNGIN-NKMMMXOESA-N calcitriol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-NKMMMXOESA-N 0.000 title abstract description 12
- 229960005084 calcitriol Drugs 0.000 title abstract description 12
- 235000020964 calcitriol Nutrition 0.000 title abstract description 12
- 239000011612 calcitriol Substances 0.000 title abstract description 12
- 150000001875 compounds Chemical class 0.000 claims abstract description 127
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 claims abstract description 20
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 claims abstract description 10
- 125000001412 tetrahydropyranyl group Chemical group 0.000 claims abstract description 8
- HQAXHIGPGBPPFU-UHFFFAOYSA-N 2-prop-2-ynoxyoxane Chemical compound C#CCOC1CCCCO1 HQAXHIGPGBPPFU-UHFFFAOYSA-N 0.000 claims abstract description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 82
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- 239000001257 hydrogen Substances 0.000 claims description 8
- -1 t-butyldimethylsilyl group Chemical group 0.000 claims description 7
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- CWMFRHBXRUITQE-UHFFFAOYSA-N trimethylsilylacetylene Chemical group C[Si](C)(C)C#C CWMFRHBXRUITQE-UHFFFAOYSA-N 0.000 claims description 3
- 239000002994 raw material Substances 0.000 abstract description 8
- 208000001132 Osteoporosis Diseases 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 2
- 229940124597 therapeutic agent Drugs 0.000 abstract description 2
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 53
- 239000000243 solution Substances 0.000 description 46
- 239000000203 mixture Substances 0.000 description 36
- 238000006243 chemical reaction Methods 0.000 description 35
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 34
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 33
- 239000002904 solvent Substances 0.000 description 29
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 22
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 21
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 21
- 238000000034 method Methods 0.000 description 21
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 20
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 18
- 238000010898 silica gel chromatography Methods 0.000 description 18
- 230000003595 spectral effect Effects 0.000 description 18
- 238000005160 1H NMR spectroscopy Methods 0.000 description 17
- 230000015572 biosynthetic process Effects 0.000 description 17
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 17
- 235000019341 magnesium sulphate Nutrition 0.000 description 17
- 238000003786 synthesis reaction Methods 0.000 description 17
- 238000007405 data analysis Methods 0.000 description 16
- 238000000921 elemental analysis Methods 0.000 description 16
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- 239000012044 organic layer Substances 0.000 description 15
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 10
- 229920006395 saturated elastomer Polymers 0.000 description 10
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 9
- 239000007864 aqueous solution Substances 0.000 description 8
- 239000012230 colorless oil Substances 0.000 description 8
- 239000000543 intermediate Substances 0.000 description 8
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 8
- 235000017557 sodium bicarbonate Nutrition 0.000 description 8
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- HUHXLHLWASNVDB-UHFFFAOYSA-N 2-(oxan-2-yloxy)oxane Chemical compound O1CCCCC1OC1OCCCC1 HUHXLHLWASNVDB-UHFFFAOYSA-N 0.000 description 5
- 229910052799 carbon Inorganic materials 0.000 description 5
- ARNWQMJQALNBBV-UHFFFAOYSA-N lithium carbide Chemical compound [Li+].[Li+].[C-]#[C-] ARNWQMJQALNBBV-UHFFFAOYSA-N 0.000 description 5
- 229910000027 potassium carbonate Inorganic materials 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 150000003722 vitamin derivatives Chemical class 0.000 description 5
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 4
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 229910052740 iodine Inorganic materials 0.000 description 4
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 4
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 4
- BCNZYOJHNLTNEZ-UHFFFAOYSA-N tert-butyldimethylsilyl chloride Chemical compound CC(C)(C)[Si](C)(C)Cl BCNZYOJHNLTNEZ-UHFFFAOYSA-N 0.000 description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- JEDZLBFUGJTJGQ-UHFFFAOYSA-N [Na].COCCO[AlH]OCCOC Chemical compound [Na].COCCO[AlH]OCCOC JEDZLBFUGJTJGQ-UHFFFAOYSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000011630 iodine Substances 0.000 description 3
- UBJFKNSINUCEAL-UHFFFAOYSA-N lithium;2-methylpropane Chemical compound [Li+].C[C-](C)C UBJFKNSINUCEAL-UHFFFAOYSA-N 0.000 description 3
- WGOPGODQLGJZGL-UHFFFAOYSA-N lithium;butane Chemical compound [Li+].CC[CH-]C WGOPGODQLGJZGL-UHFFFAOYSA-N 0.000 description 3
- DVSDBMFJEQPWNO-UHFFFAOYSA-N methyllithium Chemical compound C[Li] DVSDBMFJEQPWNO-UHFFFAOYSA-N 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 150000003751 zinc Chemical class 0.000 description 3
- ULDHMXUKGWMISQ-VIFPVBQESA-N (+)-carvone Chemical compound CC(=C)[C@H]1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-VIFPVBQESA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- 239000002841 Lewis acid Substances 0.000 description 2
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 238000006735 epoxidation reaction Methods 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 150000007517 lewis acids Chemical class 0.000 description 2
- WDDOQHLJFOUQMW-UHFFFAOYSA-N lithium;ethynyl(trimethyl)silane Chemical compound [Li+].C[Si](C)(C)C#[C-] WDDOQHLJFOUQMW-UHFFFAOYSA-N 0.000 description 2
- XMJHPCRAQCTCFT-UHFFFAOYSA-N methyl chloroformate Chemical compound COC(Cl)=O XMJHPCRAQCTCFT-UHFFFAOYSA-N 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 150000003138 primary alcohols Chemical class 0.000 description 2
- ZDYVRSLAEXCVBX-UHFFFAOYSA-N pyridinium p-toluenesulfonate Chemical compound C1=CC=[NH+]C=C1.CC1=CC=C(S([O-])(=O)=O)C=C1 ZDYVRSLAEXCVBX-UHFFFAOYSA-N 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000012419 sodium bis(2-methoxyethoxy)aluminum hydride Substances 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 229940079827 sodium hydrogen sulfite Drugs 0.000 description 2
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 2
- 235000010265 sodium sulphite Nutrition 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- BRLQWZUYTZBJKN-GSVOUGTGSA-N (+)-Epichlorohydrin Chemical compound ClC[C@@H]1CO1 BRLQWZUYTZBJKN-GSVOUGTGSA-N 0.000 description 1
- BRLQWZUYTZBJKN-VKHMYHEASA-N (-)-Epichlorohydrin Chemical compound ClC[C@H]1CO1 BRLQWZUYTZBJKN-VKHMYHEASA-N 0.000 description 1
- VGNCBRNRHXEODV-XXVHXNRLSA-N (6r,7r)-1-[(4s,5r)-4-acetyloxy-5-methyl-3-methylidene-6-phenylhexyl]-6-dodecoxy-4,7-dihydroxy-2,8-dioxabicyclo[3.2.1]octane-3,4,5-tricarboxylic acid Chemical compound C([C@@H](C)[C@H](OC(C)=O)C(=C)CCC12[C@H](O)[C@H](C(O2)(C(O)=O)C(O)(C(O1)C(O)=O)C(O)=O)OCCCCCCCCCCCC)C1=CC=CC=C1 VGNCBRNRHXEODV-XXVHXNRLSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- CXBDYQVECUFKRK-UHFFFAOYSA-N 1-methoxybutane Chemical compound CCCCOC CXBDYQVECUFKRK-UHFFFAOYSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- LNORZGMNIVDXEZ-UHFFFAOYSA-N 3-diethoxyphosphoryloxypropanoic acid Chemical compound C(C)OP(=O)(OCC)OCCC(=O)O LNORZGMNIVDXEZ-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- AQBHICRZARWPKS-UHFFFAOYSA-N C#CCC(CC#CCO)O Chemical compound C#CCC(CC#CCO)O AQBHICRZARWPKS-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 238000006546 Horner-Wadsworth-Emmons reaction Methods 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- LNAMMBFJMYMQTO-FNEBRGMMSA-N chloroform;(1e,4e)-1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].ClC(Cl)Cl.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1.C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 LNAMMBFJMYMQTO-FNEBRGMMSA-N 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- WMKGGPCROCCUDY-PHEQNACWSA-N dibenzylideneacetone Chemical compound C=1C=CC=CC=1\C=C\C(=O)\C=C\C1=CC=CC=C1 WMKGGPCROCCUDY-PHEQNACWSA-N 0.000 description 1
- XEBCWEDRGPSHQH-UHFFFAOYSA-N diisopropyl tartrate Chemical compound CC(C)OC(=O)C(O)C(O)C(=O)OC(C)C XEBCWEDRGPSHQH-UHFFFAOYSA-N 0.000 description 1
- GPAYUJZHTULNBE-UHFFFAOYSA-N diphenylphosphine Chemical compound C=1C=CC=CC=1PC1=CC=CC=C1 GPAYUJZHTULNBE-UHFFFAOYSA-N 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 150000002497 iodine compounds Chemical class 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 238000005870 sharpless asymmetric epoxidation reaction Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 125000003808 silyl group Chemical group [H][Si]([H])([H])[*] 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- ILJSQTXMGCGYMG-UHFFFAOYSA-N triacetic acid Chemical compound CC(=O)CC(=O)CC(O)=O ILJSQTXMGCGYMG-UHFFFAOYSA-N 0.000 description 1
- CYTQBVOFDCPGCX-UHFFFAOYSA-N trimethyl phosphite Chemical compound COP(OC)OC CYTQBVOFDCPGCX-UHFFFAOYSA-N 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
Landscapes
- Epoxy Compounds (AREA)
- Pyrane Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は骨粗鬆症その他の疾病に
対する治療薬カルシトリオール及びその関連のビタミン
誘導体を製造する際の後記式9で示されるカルシトリオ
ールのA環部に相当する重要中間体を製造するための新
規な化合物及びその製法に関する。FIELD OF THE INVENTION The present invention produces an important intermediate corresponding to the A ring portion of calcitriol represented by the following formula 9 when producing calcitriol and its related vitamin derivative for the treatment of osteoporosis and other diseases. The present invention relates to a novel compound and a method for producing the same.
【0002】[0002]
【従来の技術】カルシトリオール及びその関連のビタミ
ン誘導体は骨粗鬆症その他の疾病に対する治療薬として
用いられており、この製法について、とくにカルシトリ
オールのA環部分の合成方法についてより効率的な方法
の開発が求められてきた。2. Description of the Related Art Calcitriol and its related vitamin derivatives are used as therapeutic agents for osteoporosis and other diseases, and a more efficient method has been developed for this method, particularly for the method for synthesizing the A ring portion of calcitriol. I have been asked.
【0003】後記式9に示されるカルシトリオールのA
環部に相当する化合物の製法は知られている(E.G.Bagg
iolini等、J.Am.Chem.Soc.,104,2945(1982))。また、
本発明においてA環部に相当する化合物の中間体である
式7cに代表される鎖化合物の製法も知られている(B.
M.Trost 等、J.Am.Chem.Soc.,114,9836(1992))。A of calcitriol represented by the following formula 9
A method for producing a compound corresponding to the ring portion is known (EGBagg
iolini et al., J. Am. Chem. Soc., 104, 2945 (1982)). Also,
In the present invention, a method for producing a chain compound represented by the formula 7c which is an intermediate of a compound corresponding to the A ring part is also known (B.
M. Trost et al., J. Am. Chem. Soc., 114, 9836 (1992)).
【0004】[0004]
【発明が解決しようとする課題】上記公知の方法は工業
的には問題となる点が多くより優れた方法の開発が求め
られていた。即ち前者の方法ではd−カルボンを原料と
し、立体特異的にエポキシ化した後ホーナー・エモンス
反応でジエチル(カルボキシエチル)リン酸エステルの
カルバニオンと反応させ、生じたα,β−不飽和エステ
ルの9:1のZ体・E体混合物をシリカゲル・カラムで
分離し, Z体を除去し、エポキシ基を開環後、ジアセテ
ートとした後イソプロペニル基をアセチル基、次いでア
セテートへと酸化し、トリアセテートとし、加水分解し
てトリオールとした後、2級水酸基のみt−ブチルジメ
チルシリル基で保護し、脱水してエキソメチレン基に変
換する方法で式 9a,9bで示される化合物が合成さ
れているが、工程も長く、途中の反応も副反応を起こさ
ないように非常に注意を要するプロセスである。The above-mentioned known methods have many industrial problems, and there has been a demand for the development of more excellent methods. That is, in the former method, d-carvone is used as a raw material, and after stereospecifically epoxidizing it, it is reacted with a carbanion of diethyl (carboxyethyl) phosphate by a Horner-Emmons reaction to produce 9 of α, β-unsaturated ester. The Z-form / E-form mixture of 1 is separated by a silica gel column, the Z-form is removed, the epoxy group is opened, the diacetate is converted, and the isopropenyl group is oxidized to an acetyl group and then to an acetate to give triacetate. Then, the compound represented by the formula 9a or 9b is synthesized by a method in which only the secondary hydroxyl group is protected with a t-butyldimethylsilyl group after being hydrolyzed to a triol, and dehydration is performed to convert it into an exomethylene group. However, the process is long, and very careful not to cause side reactions during the reaction.
【0005】後者の方法では中間体の3−ヒドロキシ−
5−t−ブチルジフェニルシロキシオクタ−7−イン−
1−エンのシン体、アンチ体を分離しなければならず、
経済効率を上げるためにはシン体の3位の水酸基を光延
法で立体反転させてアンチ体にする必要があり、さらに
上記のシン体のラセミ混合物のうち(+)体を動力学的
な分割法の原理で選択的に不斉エポキシ化して除去し、
未反応(−)体を回収する必要があり、光学純度の良い
製品を大量に得ることは容易ではなく、工業的な製法と
しては操作が煩雑な欠点があった。In the latter method, the intermediate 3-hydroxy-
5-t-butyldiphenylsiloxyoct-7-yne-
The syn-form and anti-form of 1-ene must be separated,
In order to improve the economic efficiency, it is necessary to sterically invert the hydroxyl group at the 3-position of the syn-form to the anti-form by the Mitsunobu method. Further, the (+)-form of the racemic mixture of the syn-form is dynamically resolved. Asymmetric epoxidation is selectively removed by the principle of the method,
It is necessary to collect the unreacted (-) form, and it is not easy to obtain a large amount of products with good optical purity, and there is a drawback that the operation is complicated as an industrial production method.
【0006】[0006]
【課題を解決するための手段】本発明者は上記に鑑み、
効率良くまた副生成物のすくない、簡単な反応経路でカ
ルシトリオール及びその関連のビタミン誘導体のA環部
の重要中間体、即ち式8a,8bおよび9a,9bで表
される化合物を得る方法について鋭意検討した結果、式
1で表される化合物S−5−ヒドロキシ−オクタ−2,
7−ジイン−1−オールおよびそのシリル誘導体を原料
に下記の反応経路(I)に従い、目的とする上記の化合
物を得る新たな方法を見いだした。下記反応経路中、TM
S はトリメチルシリル基、THP はテトラヒドロピラニル
基、TBS はt−ブチルジメチルシリル基をそれぞれ表
す。In view of the above, the present inventor has made
A method for obtaining a key intermediate of the A ring part of calcitriol and its related vitamin derivatives, that is, a compound represented by the formulas 8a, 8b and 9a, 9b, efficiently and with a simple reaction route in which there are few byproducts As a result of examination, the compound S-5-hydroxy-octa-2 represented by the formula 1
A new method for obtaining the above-mentioned compound of interest was found according to the following reaction route (I) using 7-diyn-1-ol and its silyl derivative as raw materials. TM in the following reaction path
S represents a trimethylsilyl group, THP represents a tetrahydropyranyl group, and TBS represents a t-butyldimethylsilyl group.
【0007】反応経路(I)Reaction pathway (I)
【化4】 [Chemical 4]
【0008】本発明は下記の式1で表される化合物S−
5−ヒドロキシ−オクタ−2,7−ジイン−1−オール
とそのシリル誘導体及びその製法である。The present invention is a compound S-represented by the following formula 1.
5-Hydroxy-octa-2,7-diyn-1-ol and silyl derivatives thereof and a method for producing the same.
【0009】[0009]
【化5】 (但しR1 は水素もしくはトリメチルシリル基を,R2
は水素もしくは t−ブチルジメチルシリル基を, R3 は
テトラヒドロピラニル基もしくは水素を表す。)[Chemical 5] (However, R 1 is hydrogen or trimethylsilyl group, R 2
Represents hydrogen or a t-butyldimethylsilyl group, and R 3 represents a tetrahydropyranyl group or hydrogen. )
【0010】以下反応経路Iによって本発明を説明す
る。式1で表される本発明の化合物S−5−ヒドロキシ
−オクタ−2,7−ジイン−1−オールとそのシリル誘
導体は次のようにして製造することができる。即ち、プ
ロパルギルテトラヒドロピラニルエーテルから得られる
リチウムアセチリドを式2で表される化合物とトリフル
オロボロン・エーテレート存在下に反応させるとR1 が
トリメチルシリル基,R2 が水素及びR3 がテトラヒド
ロピラニル基の式1aの化合物が得られる。またR−
5,6−オキシラニルヘキサ−2−イニルテトラヒドロ
ピラニルエーテル(3)をリチウムトリメチルシリルア
セチリドと反応させても上記の1aの化合物を得ること
ができる。The present invention will be described below with reference to Reaction Route I. The compound S-5-hydroxy-octa-2,7-diyn-1-ol of the present invention represented by Formula 1 and its silyl derivative can be produced as follows. That is, when lithium acetylide obtained from propargyl tetrahydropyranyl ether is reacted with a compound represented by the formula 2 in the presence of trifluoroboron etherate, R 1 is a trimethylsilyl group, R 2 is hydrogen and R 3 is a tetrahydropyranyl group. A compound of formula 1a is obtained. Also R-
The compound of 1a above can also be obtained by reacting 5,6-oxiranylhex-2-ynyltetrahydropyranyl ether (3) with lithium trimethylsilylacetylide.
【0011】プロパルギルテトラヒドロピラニルエーテ
ルから得られるリチウムアセチリドと式2の化合物の反
応は次のようにして行なうことができる。プロパルギル
テトラヒドロピラニルエーテルを例えばテトラヒドロフ
ラン、ジエチルエーテル、エチレングリコールなどのエ
ーテル類、又はヘキサンなどの炭化水素類を溶媒とし、
メチルリチウム、n−ブチルリチウム、 sec−ブチルリ
チウム、t−ブチルリチウムなどの強塩基の等量以上と
作用させて生成するリチウムアセチリドを式2の化合物
S−5−トリメチルシリル−1,2−オキシラニルペン
タ−4−イン(2)とルイス酸、例えばトリフルオロボ
ロン・エーテレート存在下に反応させると式1aの化合
物が得られる。この反応は−30℃〜− 100℃の低温で行
なうことが望ましい。この反応は触媒なしでも進行する
が、上記のごときルイス酸を添加すると反応が加速され
る。The reaction of lithium acetylide obtained from propargyl tetrahydropyranyl ether with the compound of formula 2 can be carried out as follows. Propargyl tetrahydropyranyl ether as a solvent, for example, tetrahydrofuran, diethyl ether, ethers such as ethylene glycol, or hydrocarbons such as hexane,
Lithium acetylide formed by reacting with methyl lithium, n-butyllithium, sec-butyllithium, t-butyllithium or the like with an equal amount or more of a strong base is used to form a compound of formula 2, S-5-trimethylsilyl-1,2-oxila Reaction of nylpent-4-yne (2) with a Lewis acid, such as trifluoroboron etherate, provides a compound of formula 1a. It is desirable to carry out this reaction at a low temperature of -30 ° C to -100 ° C. This reaction proceeds even without a catalyst, but the addition of the Lewis acid as described above accelerates the reaction.
【0012】またR−5,6−オキシラニルヘキサ−2
−イニルテトラヒドロピラニルエーテル(3)とリチウ
ムトリメチルシリルアセチリドとの反応は次のように行
なうことができる。即ち、トリメチルシリルアセチレン
を例えばテトラヒドロフラン、ジエチルエーテル、エチ
レングリコールなどのエーテル類、又はヘキサンなどの
炭化水素類を溶媒とし、メチルリチウム、n−ブチルリ
チウム、 sec−ブチルリチウム、t−ブチルリチウムな
どの強塩基の等量以上と作用させて生成するリチウムア
セチリドを式3の化合物と反応させると式1aの化合物
が得られる。この反応は−30℃〜− 100℃の低温で行な
うことが望ましい。R-5,6-oxiranylhexa-2
The reaction of -inyl tetrahydropyranyl ether (3) with lithium trimethylsilyl acetylide can be carried out as follows. That is, trimethylsilylacetylene is used as a solvent, for example, ethers such as tetrahydrofuran, diethyl ether, and ethylene glycol, or hydrocarbons such as hexane, and a strong base such as methyllithium, n-butyllithium, sec-butyllithium, and t-butyllithium. The compound of formula 1a is obtained by reacting the lithium acetylide formed by reacting with the compound of formula 3 in an amount equal to or greater than It is desirable to carry out this reaction at a low temperature of -30 ° C to -100 ° C.
【0013】原料のS−5−トリメチルシリル−1,2
−オキシラニルペンタ−4−イン(2)は高光学純度の
R−エピクロルヒドリンからTetrahedron Asymmetry,3,
853(1992) 記載の方法で製造できる。またもう一つの原
料R−5,6−オキシラニルヘキサ−2−イニルテトラ
ヒドロピラニルエーテル(3)はAngew.Chem.Int.Ed,En
gl.,28,1272(1989) 記載の方法でS−エピクロロヒドリ
ンから製造できる。Starting material S-5-trimethylsilyl-1,2
-Oxiranyl penta-4-yne (2) was prepared from high optical purity R-epichlorohydrin by Tetrahedron Asymmetry, 3,
It can be produced by the method described in 853 (1992). Another raw material R-5,6-oxiranyl hexa-2-ynyl tetrahydropyranyl ether (3) is Angew.Chem.Int.Ed, En.
It can be prepared from S-epichlorohydrin by the method described in gl., 28, 1272 (1989).
【0014】式1aの化合物から式1b,1c,1dの
化合物への変換は次のように行なう。式1aの化合物を
ジメチルホルムアミド中でイミダゾール存在下にt−ブ
チルジメチルシリルクロライドと反応させるとS−8−
トリメチルシリル−5−t−ブチルジメチルシロキシ−
オクタ−2,7−ジイニルテトラヒドロピラニルエーテ
ル(1b)が得られる。式1bの化合物を触媒量のピリ
ジニウムp−トルエンスルフォナート存在下メタノール
中で加水分解すると一級アルコール(1c)が得られ
る。また式1cの化合物をメタノール中で炭酸カリウム
と加熱するとトリメチルシリル基が脱離して式1dの化
合物を与える。The conversion of the compound of formula 1a into the compound of formulas 1b, 1c and 1d is carried out as follows. Reaction of a compound of formula 1a with t-butyldimethylsilyl chloride in dimethylformamide in the presence of imidazole results in S-8-
Trimethylsilyl-5-t-butyldimethylsiloxy-
Octa-2,7-diynyl tetrahydropyranyl ether (1b) is obtained. The primary alcohol (1c) is obtained by hydrolyzing the compound of formula 1b in methanol in the presence of a catalytic amount of pyridinium p-toluenesulfonate. Also, heating a compound of formula 1c with potassium carbonate in methanol releases the trimethylsilyl group to give a compound of formula 1d.
【0015】本発明の式1で表される化合物からカルシ
トリオール及びその関連のビタミン誘導体を製造する際
のA環部に相当する重要中間体、即ち式8a,8b及び
式9a,9bで表される化合物の製造は反応経路(I)
に従い、次のようにして行なうことができる。In the production of calcitriol and its related vitamin derivatives from the compound of formula 1 of the present invention, an important intermediate corresponding to the A ring part, that is, formula 8a, 8b and formula 9a, 9b Reaction route (I)
Then, it can be performed as follows.
【0016】式1cで表される化合物をエーテル、t−
ブチルメチルエーテル、1,2ジメトキシエタン、テト
ラヒドロフラン、ジオキサン等の溶媒中で過剰量(約5
等量)のナトリウムビス(メトキシエトキシ)アルミニ
ウムハイドリドで還元すると2位のアセチレンが部分還
元され、S−E−8−トリメチルシリル−5−t−ブチ
ルジメチルシロキシ−オクタ−2−エン−7−イン−1
−オール(4a)とS−E−5−t−ブチルジメチルシ
ロキシ−オクタ−2−エン−7−イン−1−オール(4
b)が各々65%,32%の収率で得られる。これらは容易
に分離することができるが、混合物のまま用いることも
できる。また、式1dの化合物を同様に部分還元しても
収率27%と低いが式4bの化合物のみを得ることができ
る。なお,式4aの化合物も同様にC1 〜C4 アルコー
ル等の溶媒中で炭酸ナトリウム、炭酸カリウム等の塩基
と加熱することによりトリメチルシリル基を脱離させて
ほぼ定量的に式4bの化合物に変換することができる。The compound represented by the formula 1c is ether, t-
Excess amount (about 5%) in a solvent such as butyl methyl ether, 1,2 dimethoxyethane, tetrahydrofuran and dioxane.
Reduction with an equivalent amount of sodium bis (methoxyethoxy) aluminum hydride partially reduces the acetylene at the 2-position to give S-E-8-trimethylsilyl-5-t-butyldimethylsiloxy-oct-2-ene-7-yne. -1
-Ol (4a) and S-E-5-t-butyldimethylsiloxy-oct-2-en-7-yn-1-ol (4
b) is obtained in yields of 65% and 32% respectively. These can be easily separated, but can also be used as a mixture. Further, even if the compound of formula 1d is similarly partially reduced, only the compound of formula 4b can be obtained although the yield is as low as 27%. The compound of formula 4a is also converted into the compound of formula 4b almost quantitatively by removing the trimethylsilyl group by heating with a base such as sodium carbonate or potassium carbonate in a solvent such as a C 1 -C 4 alcohol. can do.
【0017】式4aの化合物をジクロロメタン、クロロ
ホルム、四塩化炭素、1,2−ジクロロエタン等の溶媒
中、m−クロロ過安息香酸で酸化すると小量のα−エポ
キシドとともに式6aで表される望ましい配置をもつβ
−エポキシド化合物が収率73%で得られる。式6aの化
合物は香月-Sharpless不斉エポキシ化の条件、即ちL−
酒石酸ジイソプロピル存在下で式4aの化合物をエポキ
シ化するとほぼ定量的にえられる。式4bの化合物から
も同様にm−クロロ過安息香酸で酸化して式6aと同じ
配置を持つβ−エポキシド化合物6cが収率74%で得ら
れる。Oxidation of a compound of formula 4a with m-chloroperbenzoic acid in a solvent such as dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane, etc., together with a small amount of α-epoxide, provides the desired configuration of formula 6a. Β with
An epoxide compound is obtained with a yield of 73%. The compound of the formula 6a is subjected to the condition of Kazuki-Sharpless asymmetric epoxidation, namely, L-
Epoxidation of the compound of formula 4a in the presence of diisopropyl tartrate gives almost quantitative results. Similarly, from the compound of formula 4b, β-epoxide compound 6c having the same configuration as that of formula 6a can be obtained by oxidation with m-chloroperbenzoic acid in a yield of 74%.
【0018】次に式6a及び6cの化合物をトリフェニ
ルホスフィン、イミダゾール存在下でヨウ素と反応させ
るとそれぞれ式6b及び6dのヨウ素化合物が得られ
る。式6bのヨウ化物を酢酸を含むC1 〜C4 アルコー
ル等の溶媒中で活性化させた亜鉛末と反応させると式7
aの化合物5R,3R−8−トリメチルシリル−5−t
−ブチルジメチルシリル−3−ヒドロキシ−オクタ−7
−イン−1−エンが収率85%で得られる。式7aの化合
物をC1 〜C4 アルコール等の溶媒中で炭酸ナトリウ
ム、炭酸カリウム等の塩基と加熱すると8位のシリル基
が脱離した式7bの化合物がほぼ定量的に得られる。ま
た式7bの化合物は式6dの化合物を酢酸を含むメタノ
ール中で活性化された亜鉛と反応させることによっても
得られる。これをジメチルホルムアミド中、イミダゾー
ル、ジメチルアミノピリジン共存下にt−ブチルジメチ
ルシリルクロリドでシリル化して式7cの化合物とし、
メチルリチウム、n−ブチルリチウム、 sec−ブチルリ
チウム、t−ブチルリチウム等のC1 〜C4 のアルキル
リチウムでリチウムアセチリドとした後、クロロ炭酸メ
チルあるいはクロロ炭酸メチルと反応させると目的とす
るカルシトリオール及びその関連の重要中間体の一つで
ある式8a,8bの鎖状化合物が得られる。式8a,8
bの化合物をトリス(ジベンジリデンアセトン)ジパラ
ジウム・クロロフォルム錯体を触媒として環化反応を行
うと目的とするカルシトリオール及びその関連化合物の
もう一つの重要中間体、式9a,9bで表されるジアル
キリデンシクロヘキサン誘導体が得られる。Next, the compounds of formulas 6a and 6c are reacted with iodine in the presence of triphenylphosphine and imidazole to obtain iodine compounds of formulas 6b and 6d, respectively. Reaction of the iodide of formula 6b with zinc dust activated in a solvent such as a C 1 -C 4 alcohol containing acetic acid yields formula 7
a compound 5R, 3R-8-trimethylsilyl-5-t
-Butyldimethylsilyl-3-hydroxy-octa-7
-In-1-ene is obtained with a yield of 85%. When the compound of formula 7a is heated with a base such as sodium carbonate or potassium carbonate in a solvent such as a C 1 -C 4 alcohol, a compound of formula 7b in which the silyl group at the 8-position is eliminated is obtained almost quantitatively. The compound of formula 7b can also be obtained by reacting the compound of formula 6d with activated zinc in methanol containing acetic acid. This was silylated with t-butyldimethylsilyl chloride in dimethylformamide in the presence of imidazole and dimethylaminopyridine to give a compound of formula 7c,
The target calcitriol is obtained by reacting with methyl chlorocarbonate or methyl chlorocarbonate after forming lithium acetylide with C 1 to C 4 alkyllithium such as methyllithium, n-butyllithium, sec-butyllithium, and t-butyllithium. And a chain compound of the formula 8a, 8b, which is one of the important intermediates related thereto. Formula 8a, 8
When the compound of b is subjected to a cyclization reaction using a tris (dibenzylideneacetone) dipalladium-chloroform complex as a catalyst, another important intermediate of calcitriol and its related compounds, which is represented by the formulas 9a and 9b, is used. An alkylidenecyclohexane derivative is obtained.
【0019】[0019]
実施例1 <式1aの化合物の合成>トリメチルシリルアセチレン
( 6.8g,69.4mM)のテトラヒドロフラン( 110ml)溶液
に−78℃で 1.56M n−ブチルリチウムのn−ヘキサン
溶液( 37ml,57.8mM)を徐々に滴下し、同温度で 1.5時
間攪拌し、さらにトリフルオロボロン・エーテル錯体
(7.2ml,57.8mM)を徐々に滴下し、同温度で 0.5時間攪
拌した。この反応液に式3の化合物( 7.6g,38.6mM)の
テトラヒドロフラン(10ml)溶液を−78℃で徐々に滴下
し、同温度で 2.5時間攪拌した後、室温まで徐々に昇温
した。この反応液に水(20ml)を加え、エーテル 300ml
で2回抽出した。合わせた有機層を硫酸マグネシウムで
乾燥し、減圧下に溶媒を留去した。残渣をシリカゲルカ
ラムクロマトグラフィーに付し、エーテル/n−ヘキサ
ン( 1:3 )の留分から無色の式1aの化合物8.8gを得
た。収率は78%、ただし原料の回収を考慮すると収率は
82%であった。Example 1 <Synthesis of Compound of Formula 1a> A solution of trimethylsilylacetylene (6.8 g, 69.4 mM) in tetrahydrofuran (110 ml) was gradually added with a solution of 1.56 M n-butyllithium in n-hexane (37 ml, 57.8 mM) at -78 ° C. To the mixture, the mixture was stirred at the same temperature for 1.5 hours, trifluoroboron-ether complex (7.2 ml, 57.8 mM) was gradually added dropwise, and the mixture was stirred at the same temperature for 0.5 hours. A solution of the compound of formula 3 (7.6 g, 38.6 mM) in tetrahydrofuran (10 ml) was gradually added dropwise to this reaction solution at -78 ° C, and the mixture was stirred at the same temperature for 2.5 hours and then gradually warmed to room temperature. Water (20 ml) was added to the reaction mixture, and ether was added to 300 ml.
It was extracted twice with. The combined organic layers were dried over magnesium sulfate, and the solvent was evaporated under reduced pressure. The residue was subjected to silica gel column chromatography, and 8.8 g of a colorless compound of the formula 1a was obtained from a fraction of ether / n-hexane (1: 3). The yield is 78%, but considering the recovery of raw materials, the yield is
It was 82%.
【0020】また式1aの化合物は次の方法でも合成で
きた。即ち、プロパルギルテトラヒドロピラニルエーテ
ル(2.0g,13.64mM)のテトラヒドロフラン(20ml)溶液
に−78℃で1.4M n−ブチルリチウムのn−ヘキサン溶
液( 7.8ml,10.91mM)を徐々に滴下し、同温度で 0.5時
間攪拌し、さらにトリフルオロボロン・エーテル錯体
( 1.3ml,10.91mM)を徐々に滴下し、同温度で 0.5時間
攪拌した。この反応液に式 2の化合物( 1.4g,9.09mM)
のテトラヒドロフラン( 5ml)溶液を−78℃で徐々に滴
下し、同温度で 2.5時間攪拌した後、室温まで徐々に昇
温した。この反応液に水(20ml)を加え、エーテル 250
mlで2回抽出した。合わせた有機層を硫酸マグネシウム
で乾燥し、減圧下に溶媒を留去した。残渣をシリカゲル
カラムクロマトグラフィーに付し、エーテル/n−ヘキ
サン( 1:3 )の留分から無色の式1の化合物 1.79gを
得た。収率は67%であった。この方法で得た式1aの化
合物のスペクトルデータは先の方法で得た化合物と一致
した。式1aの化合物のスペクトルデータおよび元素分
析結果は以下の通りである。The compound of formula 1a can also be synthesized by the following method. That is, 1.4M n-butyllithium n-hexane solution (7.8 ml, 10.91 mM) was gradually added dropwise to a tetrahydrofuran (20 ml) solution of propargyl tetrahydropyranyl ether (2.0 g, 13.64 mM) at the same temperature. The mixture was stirred for 0.5 hour, and a trifluoroboron-ether complex (1.3 ml, 10.91 mM) was gradually added dropwise, followed by stirring at the same temperature for 0.5 hour. Compound of Formula 2 (1.4g, 9.09mM) in this reaction mixture
Tetrahydrofuran (5 ml) solution of was slowly added at -78 ° C, and the mixture was stirred at the same temperature for 2.5 hours, and then gradually warmed to room temperature. Water (20 ml) was added to the reaction solution, and ether 250 was added.
Extracted twice with ml. The combined organic layers were dried over magnesium sulfate, and the solvent was evaporated under reduced pressure. The residue was subjected to silica gel column chromatography, and 1.79 g of a colorless compound of the formula 1 was obtained from a fraction of ether / n-hexane (1: 3). The yield was 67%. The spectral data of the compound of formula 1a obtained by this method was in agreement with the compound obtained by the previous method. The spectral data and elemental analysis results of the compound of formula 1a are as follows.
【0021】IRνmax (neat)cm-1 ; 3438 , 2954 , 2
872 , 2174 , 1249 , 1025 , 841。1 H−NMR (300MHz , CDCl3); δ4.77(t, 1H, J=2.9H
z), 4.28( dt, 1H, J=15.4, 2.2Hz),4.19( dt, 1
H, J=1.8, 15.8Hz), 3.94〜3.76( m,2H), 3.57〜3.
45( m,1H), 2.50(d, 1H, J=6.2Hz), 2.62〜2.38
( m,4H), 2.87〜2.44( m,6H), 0.13( s, 9H)。 MS ; 293(M+ −H+ ), 85( 100%)。 Anal. Calcd. for C16H26O3Si, C;65.27, H;8.91。 Found: C;65.01, H;8.85。IRν max (neat) cm -1 ; 3438, 2954, 2
872, 2174, 1249, 1025, 841. 1 H-NMR (300MHz, CDCl 3 ); δ 4.77 (t, 1H, J = 2.9H
z), 4.28 (dt, 1H, J = 15.4, 2.2Hz), 4.19 (dt, 1
H, J = 1.8, 15.8Hz), 3.94 to 3.76 (m, 2H), 3.57 to 3.
45 (m, 1H), 2.50 (d, 1H, J = 6.2Hz), 2.62 to 2.38
(M, 4H), 2.87 to 2.44 (m, 6H), 0.13 (s, 9H). MS; 293 (M + -H + ), 85 (100%). Anal. Calcd. For C 16 H 26 O 3 Si, C; 65.27, H; 8.91. Found: C; 65.01, H; 8.85.
【0022】実施例2 <式1bの化合物の合成>式1aの化合物( 2.1g,7.11
mM)のジメチルホルムアミド(18ml)溶液に室温でイミ
ダゾール(1.8ml,27.0mM)とt−ブチルジメチルシリル
クロリド(1.7mg,11.4mM)を加えて6時間攪拌した。こ
の反応液に水(10ml)を加え、エーテル 200mlで2回抽
出した。合わせた有機層を硫酸マグネシウムで乾燥し、
減圧下に溶媒を留去した。残渣をシリカゲルカラムクロ
マトグラフィーに付し、エーテル/n−ヘキサン( 1:
20)の留分から無色油状の式1bの化合物2.9gを得た。
収率はほぼ定量的であった。式1bの化合物のスペクト
ルデータおよび元素分析結果は以下の通りである。Example 2 <Synthesis of Compound of Formula 1b> Compound of Formula 1a (2.1 g, 7.11
To a dimethylformamide (18 ml) solution of mM) at room temperature, imidazole (1.8 ml, 27.0 mM) and t-butyldimethylsilyl chloride (1.7 mg, 11.4 mM) were added and stirred for 6 hours. Water (10 ml) was added to the reaction solution, and the mixture was extracted twice with 200 ml of ether. The combined organic layers are dried over magnesium sulfate,
The solvent was distilled off under reduced pressure. The residue was subjected to silica gel column chromatography, and ether / n-hexane (1:
From the fraction (20) there was obtained 2.9 g of the compound of formula 1b as a colorless oil.
The yield was almost quantitative. The spectral data and elemental analysis results of the compound of formula 1b are as follows.
【0023】IRνmax (neat)cm-1; 2954 , 2856 , 21
76 , 1250 , 1107 , 1025 , 840 。1 H−NMR (300MHz , CDCl3); δ4.79(t, 1H, J=2.9H
z), 4.28( dt, 1H, J=15.4, 2.2Hz),4.18( dt, 1
H, J=2.2, 15.8Hz), 4.00〜3.78( m, 2H), 3.58〜3.
47( m, 1H), 2.53( dd, 1H, J=5.5, 16.9Hz), 2.39
( dd, 1H, J=6.2, 16.8Hz),2.59〜2.34( m, 2H),
1.89〜1.46( m, 6H), 0.89( s, 9H),0.14( s, 9
H), 0.11( s, 3H), 0.10( s, 3H)。 MS ; 351(M+ −t−Bu), 107( 100%), 85( 100
%)。 Anal. Calcd. for C18H31O3Si2 , C;64.67, H;9.8
7。 Found: C;64.41, H;9.96。IR ν max (neat) cm -1 ; 2954, 2856, 21
76, 1250, 1107, 1025, 840. 1 H-NMR (300 MHz, CDCl 3 ); δ4.79 (t, 1H, J = 2.9H
z), 4.28 (dt, 1H, J = 15.4, 2.2Hz), 4.18 (dt, 1
H, J = 2.2, 15.8Hz), 4.00 to 3.78 (m, 2H), 3.58 to 3.
47 (m, 1H), 2.53 (dd, 1H, J = 5.5, 16.9Hz), 2.39
(Dd, 1H, J = 6.2, 16.8Hz), 2.59 to 2.34 (m, 2H),
1.89 ~ 1.46 (m, 6H), 0.89 (s, 9H), 0.14 (s, 9
H), 0.11 (s, 3H), 0.10 (s, 3H). MS; 351 (M + -t-Bu), 107 (100%), 85 (100
%). Anal. Calcd. For C 18 H 31 O 3 Si 2 , C ; 64.67, H ; 9.8
7. Found: C; 64.41, H; 9.96.
【0024】実施例3 <式1cの化合物の合成>式1bの化合物(44.2mg, 0.
11mM)のメタノール( 1ml)溶液にピリジニウムp−ト
ルエンスルフォナート(10mg, 0.04mM)を加え、室温で
17時間攪拌した。この反応液の溶媒を減圧下に留去し、
飽和食塩水( 5ml)を加え、エーテル30mlで2回抽出し
た。合わせた有機層を硫酸マグネシウムで乾燥し、減圧
下に溶媒を留去した。残渣をシリカゲルカラムクロマト
グラフィーに付し、エーテル/n−ヘキサン(1:10)
の留分から無色油状の式1cの化合物28.4mgを得た。収
率は81%、ただし原料の回収を考慮すると収率は88%で
あった。式1cの化合物のスペクトルデータおよび元素
分析結果は以下の通りである。Example 3 <Synthesis of Compound of Formula 1c> Compound of Formula 1b (44.2 mg, 0.
Pyridinium p-toluenesulfonate (10 mg, 0.04 mM) was added to a solution of 11 mM) in methanol (1 ml) at room temperature.
It was stirred for 17 hours. The solvent of this reaction solution was distilled off under reduced pressure,
Saturated saline (5 ml) was added, and the mixture was extracted twice with 30 ml of ether. The combined organic layers were dried over magnesium sulfate, and the solvent was evaporated under reduced pressure. The residue was subjected to silica gel column chromatography, ether / n-hexane (1:10)
28.4 mg of the compound of formula 1c was obtained as a colorless oil from the fraction of The yield was 81%, but the yield was 88% considering the recovery of raw materials. The spectral data and elemental analysis results of the compound of formula 1c are as follows.
【0025】 [α]D 30; + 9.0°(C =1.01, メタノール)。 IRνmax (neat)cm-1 ; 3362 , 2956 , 2930 , 2856 ,
2176 , 1250 , 1103, 8401 H−NMR (300MHz , CDCl3); δ4.31〜4.21( m, 2
H), 3.93(quint, 1H, J=5.9Hz), 2.53( dd, 1H, J=
16.5, 5.5Hz), 2.40( dd, 1H, J=6.2, 16.8Hz),2.6
0〜2.34( m, 2H), 1.50(dd, 1H, J=6.2, 5.9Hz),
0.90( s, 9H), 0.15( s, 9H), 0.13( s, 6H)。 MS ; 324(M+ ), 267(M+ −57), 73( 100%)。 Anal. Calcd. for C17H32O1Si2 , C ; 62.90, H ; 9.9
4 。 Found: C ; 62.51, H ; 10.03 。[Α] D 30 ; + 9.0 ° (C = 1.01, methanol). IR ν max (neat) cm -1 ; 3362, 2956, 2930, 2856,
2176, 1250, 1103, 840 1 H-NMR (300MHz, CDCl 3 ); δ4.31 to 4.21 (m, 2
H), 3.93 (quint, 1H, J = 5.9Hz), 2.53 (dd, 1H, J =
16.5, 5.5Hz), 2.40 (dd, 1H, J = 6.2, 16.8Hz), 2.6
0 ~ 2.34 (m, 2H), 1.50 (dd, 1H, J = 6.2, 5.9Hz),
0.90 (s, 9H), 0.15 (s, 9H), 0.13 (s, 6H). MS; 324 (M + ), 267 (M + -57), 73 (100%). Anal. Calcd. For C 17 H 32 O 1 Si 2 , C; 62.90, H; 9.9
Four . Found: C; 62.51, H; 10.03.
【0026】実施例4 <式1dの化合物の合成>式1cの化合物( 1.38g, 4.
26mM)のメタノール(50ml)溶液に炭酸カリウム(1.47
g, 10.65mM)を室温で加え、40℃に昇温して 0.5時間攪
拌した。この反応液の溶媒を減圧下に留去し、飽和食塩
水( 5ml)を加え、エーテル30mlで2回抽出した。合わ
せた有機層を硫酸マグネシウムで乾燥し、減圧下に溶媒
を留去した。残渣をシリカゲルカラムクロマトグラフィ
ーに付し、エーテル/n−ヘキサン(1:2)の留分か
ら無色油状の式1dの化合物 1.04gを得た。収率は97%
であった。式1dの化合物のスペクトルデータおよび元
素分析結果は以下の通りである。Example 4 <Synthesis of Compound of Formula 1d> Compound of Formula 1c (1.38 g, 4.
To a solution of 26 mM) in methanol (50 ml), potassium carbonate (1.47
g, 10.65 mM) was added at room temperature, the temperature was raised to 40 ° C, and the mixture was stirred for 0.5 hour. The solvent of this reaction solution was evaporated under reduced pressure, saturated brine (5 ml) was added, and the mixture was extracted twice with 30 ml of ether. The combined organic layers were dried over magnesium sulfate, and the solvent was evaporated under reduced pressure. The residue was subjected to silica gel column chromatography, and 1.04 g of a compound of formula 1d was obtained as a colorless oily substance from a fraction of ether / n-hexane (1: 2). Yield 97%
Met. The spectral data and elemental analysis results of the compound of Formula 1d are as follows.
【0027】 [α]D 26;− 1.6°(C=0.86, メタノール)。 IRνmax (neat)cm-1 ; 3310 , 2930 , 2856 , 2228 ,
2120 , 1256 , 1110。1 H−NMR (300MHz , CDCl3 ;δ4.25(dt, 2H, J=5.9,
1.8Hz), 3.94(quint,1H, J=5.9Hz), 2.58〜2.35(
m, 4H), 2.00(t, 1H, J=2.6Hz), 1.58(t, 1H, J=5.
9Hz), 0.90( s, 9H), 0.11( s, 6H)。 MS ; 251(M+ −H+ ), 235 (M+ −OH), 213(M
+ −HC=CCH)75( 100%)。 Anal. Calcd. for C14H24O2Si , C ; 66.61, H ; 9.5
8。 Found: C ; 66.53, H ; 9.66。[Α] D 26 ; −1.6 ° (C = 0.86, methanol). IR ν max (neat) cm -1 ; 3310, 2930, 2856, 2228,
2120, 1256, 1110. 1 H-NMR (300MHz, CDCl 3 ; δ4.25 (dt, 2H, J = 5.9,
1.8Hz), 3.94 (quint, 1H, J = 5.9Hz), 2.58 ~ 2.35 (
m, 4H), 2.00 (t, 1H, J = 2.6Hz), 1.58 (t, 1H, J = 5.
9Hz), 0.90 (s, 9H), 0.11 (s, 6H). MS; 251 (M + -H + ), 235 (M + -OH), 213 (M
+ −HC = CCH) 75 (100%). Anal. Calcd. For C 14 H 24 O 2 Si, C; 66.61, H; 9.5
8. Found: C; 66.53, H; 9.66.
【0028】実施例5 <式4aの化合物の合成>式1cの化合物( 2.35g, 7.
25mM)のエーテル(50ml)溶液に35%ナトリウムビス
(2−メトキシエトキシ)アルミニウムハイドライド/
トルエン溶液(21ml, 34.8mM)を 0℃で加え、徐々に室
温まで昇温して 1時間攪拌した。この反応液に10%NaOH
水溶液( 7ml)を加えて20分間攪拌し、ジクロロメタン
300mlで2回抽出した。合わせた有機層を飽和食塩水30
mlで洗浄後、硫酸マグネシウムで乾燥し、減圧下に溶媒
を留去した。残渣をシリカゲルカラムクロマトグラフィ
ーに付し、エーテル/n−ヘキサン(1:2)の留分か
ら無色油状の式4aの化合物 1.51g(64%)と、同じく
無色油状の式4bの化合物 573mg(31%)を得た。原料
回収は44mg(2%)であった。式4aの化合物のスペク
トルデータおよび元素分析結果は以下の通りである。Example 5 <Synthesis of Compound of Formula 4a> Compound of Formula 1c (2.35 g, 7.
25 mM) in ether (50 ml) solution with 35% sodium bis (2-methoxyethoxy) aluminum hydride /
A toluene solution (21 ml, 34.8 mM) was added at 0 ° C, the temperature was gradually raised to room temperature, and the mixture was stirred for 1 hour. Add 10% NaOH to this reaction mixture.
Add an aqueous solution (7 ml) and stir for 20 minutes, then add dichloromethane.
Extracted twice with 300 ml. Combine the organic layers with saturated saline solution 30
After washing with ml, it was dried over magnesium sulfate and the solvent was distilled off under reduced pressure. The residue was subjected to silica gel column chromatography, and from the fraction of ether / n-hexane (1: 2), a colorless oily compound of the formula 4a (1.51 g, 64%) and a colorless oily compound of the formula 4b (573 mg, 31%) ) Got. The raw material recovery was 44 mg (2%). The spectral data and elemental analysis results of the compound of formula 4a are as follows.
【0029】 [α]D 28;+ 3.9°(C=0.92, メタノール)。 IRνmax (neat)cm-1 ; 3344 , 2956 , 2930 , 2898 ,
2858 , 2176 , 1250, 1101 , 840 , 773。1 H−NMR (500MHz , CDCl3); δ5.72〜5.64( m, 2H)
4.13〜4.04( m, 2H)3.83( ddd, 1H, J=5.5, 6.1, 1
1.6Hz), 2.32(d, 2H, J=6.1Hz),2.36〜2.21( m, 2
H), 1.24(dd, 1H, J=5.5, 6.1Hz), 0.87( s, 9H),
0.12( s, 9H), 0.08( s, 3H), 0.04( s, 3H)。 MS ; 325(M+ −H+ ), 269(M+ −57), 73( 100
%)。 Anal. Calcd. for C14H24O2Si , C ; 62.51, H ; 10.4
9 。 Found:C ; 62.44, H ; 10.42。[Α] D 28 ; + 3.9 ° (C = 0.92, methanol). IR ν max (neat) cm -1 ; 3344, 2956, 2930, 2898,
2858, 2176, 1250, 1101, 840, 773. 1 H-NMR (500 MHz, CDCl 3 ); δ5.72 to 5.64 (m, 2H)
4.13 ~ 4.04 (m, 2H) 3.83 (ddd, 1H, J = 5.5, 6.1, 1
1.6Hz), 2.32 (d, 2H, J = 6.1Hz), 2.36 ~ 2.21 (m, 2
H), 1.24 (dd, 1H, J = 5.5, 6.1Hz), 0.87 (s, 9H),
0.12 (s, 9H), 0.08 (s, 3H), 0.04 (s, 3H). MS; 325 (M + -H + ), 269 (M + -57), 73 (100
%). Anal. Calcd. For C 14 H 24 O 2 Si, C; 62.51, H; 10.4
9. Found: C; 62.44, H; 10.42.
【0030】実施例6 <式4bの化合物の合成>式1dの化合物( 692mg, 2.
75mM)のエーテル(12.5ml)溶液に35%ナトリウムビス
(2−メトキシエトキシ)アルミニウムハイドライド/
トルエン溶液( 7.6ml, 13.2mM)を0℃で加え、 1時間
20分攪拌後、室温まで昇温して6時間攪拌した。この反
応液に10%NaOH水溶液(4ml)を加えて20分間攪拌し、
ジクロロメタン 150mlで 2回抽出した。合わせた有機層
を飽和食塩水15mlで洗浄後、硫酸マグネシウムで乾燥
し、減圧下に溶媒を留去した。残渣をシリカゲルカラム
クロマトグラフィーに付し、エーテル/n−ヘキサン
(1:2)の留分から無色油状の式4bの化合物 188mg
を得た。収率は27%であった。式4bの化合物のスペク
トルデータおよび元素分析結果は以下の通りである。Example 6 <Synthesis of Compound of Formula 4b> Compound of Formula 1d (692 mg, 2.
75 mM) in ether (12.5 ml) solution with 35% sodium bis (2-methoxyethoxy) aluminum hydride /
Toluene solution (7.6ml, 13.2mM) was added at 0 ℃ for 1 hour.
After stirring for 20 minutes, the temperature was raised to room temperature and stirring was continued for 6 hours. To this reaction solution was added 10% NaOH aqueous solution (4 ml) and stirred for 20 minutes,
It was extracted twice with 150 ml of dichloromethane. The combined organic layers were washed with saturated saline (15 ml), dried over magnesium sulfate, and the solvent was evaporated under reduced pressure. The residue was subjected to silica gel column chromatography, and 188 mg of a compound of the formula 4b was obtained as a colorless oil from a fraction of ether / n-hexane (1: 2).
I got The yield was 27%. The spectral data and elemental analysis results of the compound of formula 4b are as follows.
【0031】 [α]D 25;− 6.0°(C=0.86, クロロフォルム) IRνmax (neat)cm-1 ; 3312, 2952 , 2932 , 2856 ,
2120 , 1100 , 835 。1 H− NMR(300MHz , CDCl3);δ5.73〜5.70( m, 2H)
4.13〜4.10( m, 2H)3.86(quint, 1H, J=5.9Hz), 2.
32(dd, 2H, J=2.6, 6.2Hz), 2.44〜2.25( m, 2H),
1.99(t, 1H, J=2.6Hz), 1.26(t, 1H, J=5.9Hz), 0.
89( s, 9H),0.08( s, 3H), 0.06( s, 3H)。 MS ; 237(M+ −OH), 215 (M+ −CH2C≡CH), 143
(M+ −111 ),75( 100%)。 Anal. Calcd. for C14H26O2Si , C ; 66.09, H ; 10.3
0 。 Found: C ; 66.04 , H ; 10.10。[Α] D 25 ; −6.0 ° (C = 0.86, chloroform) IRνmax (neat) cm −1 ; 3312, 2952, 2932, 2856,
2120, 1100, 835. 1 H-NMR (300 MHz, CDCl 3 ); δ5.73 to 5.70 (m, 2H)
4.13 ~ 4.10 (m, 2H) 3.86 (quint, 1H, J = 5.9Hz), 2.
32 (dd, 2H, J = 2.6, 6.2Hz), 2.44 to 2.25 (m, 2H),
1.99 (t, 1H, J = 2.6Hz), 1.26 (t, 1H, J = 5.9Hz), 0.
89 (s, 9H), 0.08 (s, 3H), 0.06 (s, 3H). MS; 237 (M + -OH), 215 (M + -CH 2 C≡CH), 143
(M + -111), 75 (100%). Anal. Calcd. For C14H26O2Si, C; 66.09, H; 10.3.
0. Found: C; 66.04, H; 10.10.
【0032】実施例7 <式6aの化合物の合成>式4aの化合物( 240mg, 0.
74mM)のジクロロメタン(24ml)溶液に炭酸水素ナトリ
ウム( 185mg, 2.21mM)とm−クロロ過安息香酸( 270
mg, 1.10mM)を0℃で加え、同温度で2時間攪拌した。
この反応液に0℃で飽和亜硫酸水素ナトリウム水溶液
(20ml)を加えて、20分攪拌後、室温まで昇温し、ジク
ロロメタン 120mlで2回抽出した。合わせた有機層を飽
和炭酸水素ナトリウム水溶液(20ml)、ついで飽和食塩
水(20ml)で洗浄後、硫酸マグネシウムで乾燥し、減圧
下に溶媒を留去した。残渣をシリカゲルカラムクロマト
グラフィーに付し、エーテル/n−ヘキサン(1:3)
の留分から無色油状の式6aで表されるβ−エポキシド
とその異性体であるα−エポキシドを各々 183.5mg(収
率73%), 18.4mg(収率7.3%)得た。式6aの化合物
のスペクトルデータおよび元素分析結果は以下の通りで
ある。Example 7 <Synthesis of Compound of Formula 6a> Compound of Formula 4a (240 mg, 0.
74 mM) in dichloromethane (24 ml) was added to sodium hydrogen carbonate (185 mg, 2.21 mM) and m-chloroperbenzoic acid (270
(mg, 1.10 mM) was added at 0 ° C., and the mixture was stirred at the same temperature for 2 hours.
A saturated aqueous sodium hydrogen sulfite solution (20 ml) was added to the reaction solution at 0 ° C., the mixture was stirred for 20 minutes, warmed to room temperature, and extracted twice with 120 ml of dichloromethane. The combined organic layers were washed with saturated aqueous sodium hydrogen carbonate solution (20 ml) and then saturated brine (20 ml), dried over magnesium sulfate, and the solvent was evaporated under reduced pressure. The residue was subjected to silica gel column chromatography, ether / n-hexane (1: 3).
183.5 mg (yield 73%) and 18.4 mg (yield 7.3%) of the colorless oily β-epoxide represented by the formula 6a and its isomer α-epoxide were obtained from the distillate. The spectral data and elemental analysis results of the compound of formula 6a are as follows.
【0033】 [α]D 32;−43.3°(C=1.28, クロロフォルム) IRνmax (neat)cm-1; 3446, 2954 , 2856 , 2176 , 1
744 , 1731 , 663。1 H−NMR (500MHz , CDCl3); δ4.01〜3.97( m, 1H)
3.91( ddd, 1H, J=3.1, 5.5, 12.8Hz), 3.61(ddd, 1
H, J=4.3, 7.3, 12.2 Hz),3.09〜3.05( m,1H), 2.4
1〜2.36( m, 2H),1.83〜1.73( m, 2H),1.70(dd,
1H, J=5.5, 7.3Hz), 0.87( s, 9H), 0.11( s, 9
H), 0.09( s, 6H)。 MS ; 285(M+ −57), 267 (M+ −75), 145(M+
−197 ),73( 100%)。 Anal. Calcd. for C17H34O3Si2 , C ; 59.61 , H ; 1
0.01 。 Found: C ; 59.42 , H ; 9.99 。[Α] D 32 ; −43.3 ° (C = 1.28, chloroform) IRνmax (neat) cm −1 ; 3446, 2954, 2856, 2176, 1
744, 1731, 663. 1 H-NMR (500 MHz, CDCl 3 ); δ4.01 to 3.97 (m, 1H)
3.91 (ddd, 1H, J = 3.1, 5.5, 12.8Hz), 3.61 (ddd, 1
H, J = 4.3, 7.3, 12.2 Hz), 3.09 to 3.05 (m, 1H), 2.4
1 ~ 2.36 (m, 2H), 1.83 ~ 1.73 (m, 2H), 1.70 (dd,
1H, J = 5.5, 7.3Hz), 0.87 (s, 9H), 0.11 (s, 9
H), 0.09 (s, 6H). MS; 285 (M + −57), 267 (M + −75), 145 (M +
-197), 73 (100%). Anal. Calcd. For C 17 H 34 O 3 Si 2 , C; 59.61, H; 1
0.01. Found: C; 59.42, H; 9.99.
【0034】実施例8 <式6cの化合物の合成>式4bの化合物( 1.23g, 4.
86mM)のジクロロメタン(80ml)溶液に炭酸水素ナトリ
ウム(1.22g, 14.57mM)とm−クロロ過安息香酸( 1.2
6g, 7.29mM)を0℃で加え、同温度で2時間攪拌した。
この反応液に0℃で飽和亜硫酸水素ナトリウム水溶液
(60ml)を加えて、20分攪拌後、室温まで昇温し、ジク
ロロメタン 400mlで2階抽出した。合わせた有機層を飽
和炭酸水素ナトウリム水溶液(60ml)、ついで飽和食塩
水(60ml)で洗浄後、硫酸マグネシウムで乾燥し、減圧
下に溶媒を留去した。残渣をシリカゲルカラムクロマト
グラフィーに付し、エーテル/n−ヘキサン(1:1)
の留分から無色油状の式6cで表されるβ−エポキシド
とその異性体であるα−エポキシドを各々 969.2mg(収
率74%), 80.8mg(収率6.2%)得た。式6cの化合物
のスペクトルデータおよび元素分析結果は以下の通りで
ある。Example 8 <Synthesis of Compound of Formula 6c> Compound of Formula 4b (1.23 g, 4.
86mM) in dichloromethane (80ml) in sodium hydrogen carbonate (1.22g, 14.57mM) and m-chloroperbenzoic acid (1.2m).
6 g, 7.29 mM) was added at 0 ° C., and the mixture was stirred at the same temperature for 2 hours.
A saturated aqueous sodium hydrogen sulfite solution (60 ml) was added to this reaction solution at 0 ° C., the mixture was stirred for 20 minutes, warmed to room temperature, and extracted with 400 ml of dichloromethane on the second floor. The combined organic layers were washed with a saturated aqueous sodium hydrogencarbonate solution (60 ml) and then with saturated saline (60 ml), dried over magnesium sulfate, and the solvent was evaporated under reduced pressure. The residue was subjected to silica gel column chromatography, ether / n-hexane (1: 1).
From the fraction (1), 969.2 mg (yield 74%) and 80.8 mg (yield 6.2%) of β-epoxide represented by the formula 6c and its isomer α-epoxide, respectively, were obtained. The spectral data and elemental analysis results of the compound of formula 6c are as follows.
【0035】 [α]D 27;−51.4°(C=1.04, クロロフォルム) IRνmax (neat)cm-1 ; 3422, 3310 , 2934 , 2856 ,
2120 , 1256 , 1102。1 H−NMR (300MHz , CDCl3); δ4.07〜3.99( m, 1H)
3.93( ddd, 1H, J=2.6, 5.5, 12.5Hz), 3.64( ddd,
1H, J=4.0, 7.3, 11.7Hz), 3.11(ddd, 1H, J=2.2, 4.
8, 7.0Hz), 3.00〜2.94( m, 1H), 2.40〜2.36( m,
2H), 2.00(t,1H, J=2.6Hz), 1.91〜1.74( m, 2
H),1.66(dd, 1H, J=5.5, 7.0Hz), 0.90( s, 9H),
0.11( s, 3H), 0.10( s, 3H)。 MS ; 231(M+ −39), 213 (M+ −57), 145 (M+
−125 ),75( 100%)。 HRMS Calcd. for C11H23O3Si (−CH2C=CH ), 231.
1416。 Found: 231.1429 。[Α] D 27 ; −51.4 ° (C = 1.04, chloroform) IRνmax (neat) cm −1 ; 3422, 3310, 2934, 2856,
2120, 1256, 1102. 1 H-NMR (300 MHz, CDCl 3 ); δ4.07 to 3.99 (m, 1H)
3.93 (ddd, 1H, J = 2.6, 5.5, 12.5Hz), 3.64 (ddd,
1H, J = 4.0, 7.3, 11.7Hz), 3.11 (ddd, 1H, J = 2.2, 4.
8, 7.0Hz), 3.00 ~ 2.94 (m, 1H), 2.40 ~ 2.36 (m,
2H), 2.00 (t, 1H, J = 2.6Hz), 1.91 ~ 1.74 (m, 2
H), 1.66 (dd, 1H, J = 5.5, 7.0Hz), 0.90 (s, 9H),
0.11 (s, 3H), 0.10 (s, 3H). MS; 231 (M + −39), 213 (M + −57), 145 (M +
-125), 75 (100%). HRMS Calcd. For C11H23O3Si (−CH 2 C = CH), 231.
1416. Found: 231.1429.
【0036】実施例9 <式6bの化合物の合成>式6aの化合物( 430mg, 1.
26mM)を 4 : 1−テトラヒドロフラン/アセトニトリル
(24ml; 6ml)混合溶媒に溶かし、トリフェニルホスフ
ィン( 990mg, 3.77mM), イミダゾール( 642mg, 9.43
mM), ヨウ素( 960mg, 7.54mM)を順次加え、室温で30
分間攪拌した。この反応液に飽和炭酸水素ナトリウム水
溶液(10ml)を加え、エーテル 120mlで2回抽出した。
合わせた有機層を10%亜硫酸ナトリウム水溶液10ml,飽
和炭酸水素ナトリウム水溶液10ml、飽和食塩水10mlで順
次洗浄後、硫酸マグネシウムで乾燥し、減圧下に溶媒を
留去した。残渣をシリカゲルカラムクロマトグラフィー
に付し、エーテル/n−ヘキサン(1:20)の留分から
無色油状の式6bで表されるβ−エポキシアイオダイド
486.3mg(収率85%)を得た。式6bの化合物のスペク
トルデータおよび元素分析結果は以下の通りである。Example 9 <Synthesis of Compound of Formula 6b> Compound of Formula 6a (430 mg, 1.
26 mM) was dissolved in a 4: 1-tetrahydrofuran / acetonitrile (24 ml; 6 ml) mixed solvent to prepare triphenylphosphine (990 mg, 3.77 mM) and imidazole (642 mg, 9.43).
mM) and iodine (960 mg, 7.54 mM) were added sequentially, and the mixture was stirred at room temperature for 30
Stir for minutes. A saturated aqueous sodium hydrogen carbonate solution (10 ml) was added to the reaction solution, and the mixture was extracted twice with 120 ml of ether.
The combined organic layers were washed successively with 10% aqueous sodium sulfite solution (10 ml), saturated aqueous sodium hydrogen carbonate solution (10 ml) and saturated brine (10 ml), dried over magnesium sulfate, and the solvent was evaporated under reduced pressure. The residue was subjected to silica gel column chromatography to obtain a colorless oil of β-epoxy iodide represented by the formula 6b from a fraction of ether / n-hexane (1:20).
486.3 mg (yield 85%) was obtained. The spectral data and elemental analysis results of the compound of formula 6b are as follows.
【0037】 [α]D 31;−26.3°(C=1.19, クロロフォルム) IRνmax (neat)cm-1 ; 2956 , 2898 , 2856 , 2176 ,
1252 , 1099 , 840。1 H−NMR (300MHz , CDCl3); δ4.06〜 3.94 ( m, 1
H)3.21( dd, 1H, J=5. 9, 9.9Hz ), 3.13( dd, 1
H, J=5.9, 10.3Hz), 3.05(dt, 1H, J=1.8, 6.2Hz),
2.98(dt, 1H, J=1.8, 6.6Hz), 2.43(d, 2H, J=6.2H
z), 1.85( ddd,1H, J=5.1, 7.3, 13.9Hz), 1.73( d
dd, 1H, J=4.0, 7.0, 13.9Hz), 0.90( s, 9H), 0.14
( s, 9H), 0.11( s, 3H), 0.10( s, 3H)。 MS ; 395(M+ −57), 341(M+ −111 ), 283(M
+ −169 ),73( 100%)。 Anal. Calcd. for C17H33O2Si2I , C ; 45.12, H ; 7.
35, I ;28.04。 Found: C ; 45.03 , H ; 7.22 , I ; 27.90 。[Α] D 31 ; −26.3 ° (C = 1.19, chloroform) IRνmax (neat) cm −1 ; 2956, 2898, 2856, 2176,
1252, 1099, 840. 1 H-NMR (300 MHz, CDCl 3 ); δ 4.06 to 3.94 (m, 1
H) 3.21 (dd, 1H, J = 5.9, 9.9Hz), 3.13 (dd, 1
H, J = 5.9, 10.3Hz), 3.05 (dt, 1H, J = 1.8, 6.2Hz),
2.98 (dt, 1H, J = 1.8, 6.6Hz), 2.43 (d, 2H, J = 6.2H
z), 1.85 (ddd, 1H, J = 5.1, 7.3, 13.9Hz), 1.73 (d
dd, 1H, J = 4.0, 7.0, 13.9Hz), 0.90 (s, 9H), 0.14
(S, 9H), 0.11 (s, 3H), 0.10 (s, 3H). MS; 395 (M + −57), 341 (M + −111), 283 (M
+ -169), 73 (100%). Anal. Calcd. For C 17 H 33 O 2 Si 2 I, C; 45.12, H; 7.
35, I; 28.04. Found: C; 45.03, H; 7.22, I; 27.90.
【0038】実施例10 <式6dの化合物の合成>式6cの化合物( 1.05g, 3.
89mM)の4 :1−テトラヒドロフラン/アセトニトリル
(70ml:18ml)溶液にトリフェニルホスフィン(3.06g,
11.67mM), イミダゾール(1.99g, 29.17mM), ヨウ素
(2.96g, 23.33mM)を順次加え、室温で30分間攪拌し
た。飾り英字計算―この反応液に飽和炭酸水素ナトリウ
ム水溶液(40ml)を加え、エーテル 200mlで2回抽出し
た。合わせた有機層を10%亜硫酸ナトリウム水溶液40m
l,飽和炭酸水素ナトリウム水溶液40ml、飽和食塩水40m
lで順次洗浄後、硫酸マグネシウムで乾燥し、減圧下に
溶媒を留去した。残渣をシリカゲルカラムクロマトグラ
フィーに付し、エーテル/n−ヘキサン(1:15)の留
分から無色油状の式6dで表されるβ−エポキシアイオ
ダイド 1.25g(収率84%)を得た。式6dの化合物のス
ペクトルデータおよび元素分析結果は以下の通りであ
る。Example 10 <Synthesis of Compound of Formula 6d> Compound of Formula 6c (1.05 g, 3.
89 mM) in 4: 1-tetrahydrofuran / acetonitrile (70 ml: 18 ml) solution with triphenylphosphine (3.06 g,
11.67 mM), imidazole (1.99 g, 29.17 mM), and iodine (2.96 g, 23.33 mM) were sequentially added, and the mixture was stirred at room temperature for 30 minutes. Decorative alphabet calculation-Saturated aqueous sodium hydrogen carbonate solution (40 ml) was added to this reaction solution, and the mixture was extracted twice with 200 ml of ether. Combined organic layers 40m with 10% sodium sulfite aqueous solution
l, saturated aqueous sodium hydrogen carbonate solution 40ml, saturated saline solution 40m
After sequentially washing with l, it was dried over magnesium sulfate and the solvent was distilled off under reduced pressure. The residue was subjected to silica gel column chromatography to obtain 1.25 g (yield 84%) of colorless oily β-epoxy iodide represented by the formula 6d from a fraction of ether / n-hexane (1:15). The spectral data and elemental analysis results of the compound of formula 6d are as follows.
【0039】 [α]D 29;−26.9°(C=1.17, クロロフォルム) IRνmax (neat)cm-1 ; 3306 , 2954 , 2930 , 2888 ,
2856 , 2120 , 1255, 1099 。1 H−NMR (300MHz , CDCl3); δ4.04〜3.96( m, 1H)
3.22(dd, 1H, J=5.9,9.5Hz), 3.12(dd, 1H, J=5.9,
9.9Hz), 3.06(dt, 1H, J=1.8, 5.9Hz), 2.99(ddd,
1H, J=1.8, 4.8, 7.0Hz), 2.40(dd, 2H, J=2.6, 6.2H
z), 2.00(t,1H, J=2.6Hz)1.90( ddd, 1H, J=4.8,
7.7, 14.3Hz), 1.72( ddd, 1H, J=3.7, 7.0, 13.9H
z), 0.90( s, 9H), 0.11( s, 6H )。 MS ; 341(M+ −39), 255(M+ −125 ), 185(M
+ −195 ), 127(M+−253 ), 73( 100%)。 Anal. Calcd. for C14H25O2SiI ,C ; 44.21 , H ; 6.6
3 , I ; 33.37 。 Found: C ; 44.42 , H ; 6.73 , I ; 33.59 。[Α] D 29 ; −26.9 ° (C = 1.17, chloroform) IRνmax (neat) cm −1 ; 3306, 2954, 2930, 2888,
2856, 2120, 1255, 1099. 1 H-NMR (300 MHz, CDCl 3 ); δ4.04 to 3.96 (m, 1H)
3.22 (dd, 1H, J = 5.9, 9.5Hz), 3.12 (dd, 1H, J = 5.9,
9.9Hz), 3.06 (dt, 1H, J = 1.8, 5.9Hz), 2.99 (ddd,
1H, J = 1.8, 4.8, 7.0Hz), 2.40 (dd, 2H, J = 2.6, 6.2H
z), 2.00 (t, 1H, J = 2.6Hz) 1.90 (ddd, 1H, J = 4.8,
7.7, 14.3Hz), 1.72 (ddd, 1H, J = 3.7, 7.0, 13.9H
z), 0.90 (s, 9H), 0.11 (s, 6H). MS; 341 (M + −39), 255 (M + −125), 185 (M
+ -195), 127 (M + -253), 73 (100%). Anal. Calcd. For C 14 H 25 O 2 SiI, C; 44.21, H; 6.6
3, I; 33.37. Found: C; 44.42, H; 6.73, I; 33.59.
【0040】実施例11 <式7aの化合物の合成>式6bの化合物( 456mg, 1.
01mM)のメタノール(14ml)溶液に、活性化した亜鉛
( 198mg, 3.03mM)と酢酸( 0.5ml)を順次室温で加
え、40℃に昇温して超音波に 1時間付した。この反応液
をエーテル70mlで希釈した後セライト濾過し、その瀘液
を5%塩酸水溶液10ml、飽和炭酸水素ナトリウム水溶液
(10ml)、飽和食塩水10mlで順次洗浄し、硫酸マグネシ
ウムで乾燥し、減圧下に溶媒を留去した。残渣をシリカ
ゲルカラムクロマトグラフィーに付し、エーテル/n−
ヘキサン(1:30)の留分から無色油状の式7aで表さ
れる化合物 287.2mg(収率87%)を得た。式7aの化合
物のスペクトルデータおよび元素分析結果は以下の通り
である。Example 11 <Synthesis of Compound of Formula 7a> Compound of Formula 6b (456 mg, 1.
Activated zinc (198 mg, 3.03 mM) and acetic acid (0.5 ml) were sequentially added to a solution of 01 mM) in methanol (14 ml) at room temperature, the temperature was raised to 40 ° C, and the mixture was subjected to ultrasonic waves for 1 hour. The reaction solution was diluted with 70 ml of ether and then filtered through Celite, and the filtrate was washed with 10 ml of 5% hydrochloric acid aqueous solution, 10 ml of saturated sodium hydrogen carbonate aqueous solution and 10 ml of saturated saline solution successively, dried over magnesium sulfate and dried under reduced pressure. The solvent was distilled off. The residue was subjected to silica gel column chromatography, ether / n-
287.2 mg (yield 87%) of a compound represented by the formula 7a was obtained as a colorless oil from a hexane (1:30) fraction. The spectral data and elemental analysis results of the compound of formula 7a are as follows.
【0041】 [α]D 28;−26.0°( C=1.055, クロロフォルム) IRνmax (neat)cm-1 ; 3444 , 2954 , 2858 , 2176 ,
1250 , 1098。1 H− NMR(300MHz , CDCl3); δ5.86(ddd, 1H, J=4.
9, 10.4, 17.1Hz), 5.25(bd, 1H, J=17.1Hz), 5.08
(bd, 1H, J=10.4Hz), 4.43〜4.40( m, 1H),4.15〜
4.10( m ,1H), 2.88(d, 1H, J=3.1Hz), 2.47(d, 2
H, J=6.1Hz), 1.82( ddd, 1H, J=3.1, 6.1, 14.6H
z), 1.74( ddd, 1H, J=3.7, 9.8, 13.4Hz), 0.88(
s, 9H), 0.12( s, 9H), 0.10( s, 6H)。 MS ; 269(M+ −C4H9), 215 (M+ −111 ), 159
(M+ −167 ), 73( 100%)。 Anal. Calcd. for C17H34O2Si2 ,C ; 62.54 , H ; 1
0.50。 Found:C ; 62.63 , H ; 10.52 。[Α] D 28 ; −26.0 ° (C = 1.055, chloroform) IRνmax (neat) cm −1 ; 3444, 2954, 2858, 2176,
1250, 1098. 1 H-NMR (300 MHz, CDCl 3 ); δ5.86 (ddd, 1H, J = 4.
9, 10.4, 17.1Hz), 5.25 (bd, 1H, J = 17.1Hz), 5.08
(Bd, 1H, J = 10.4Hz), 4.43 ~ 4.40 (m, 1H), 4.15 ~
4.10 (m, 1H), 2.88 (d, 1H, J = 3.1Hz), 2.47 (d, 2
H, J = 6.1Hz), 1.82 (ddd, 1H, J = 3.1, 6.1, 14.6H
z), 1.74 (ddd, 1H, J = 3.7, 9.8, 13.4Hz), 0.88 (
s, 9H), 0.12 (s, 9H), 0.10 (s, 6H). MS; 269 (M + −C 4 H 9 ), 215 (M + −111), 159
(M + -167), 73 (100%). Anal. Calcd. For C 17 H 34 O 2 Si 2 , C; 62.54, H; 1
0.50. Found: C; 62.63, H; 10.52.
【0042】実施例12 <式7bの化合物の合成>式7aの化合物( 259.9mg,
0.80mM)のメタノール( 4.5ml)溶液に炭酸カリウム
( 275mg, 1.99mM)を室温で加え、40℃に昇温して1時
間攪拌した。この反応液の溶媒を減圧下に留去し、飽和
食塩水10mlを加え、エーテル70mlで2回抽出した。合わ
せた有機層を硫酸マグネシウムで乾燥し、減圧下溶媒留
去した。残渣をシリカゲルカラムクロマトグラフィーに
付し、エーテル/n−ヘキサン(1:2)の留分から無
色油状の式7bで表される化合物 196.5mg(収率97%)
を得た。Example 12 <Synthesis of Compound of Formula 7b> Compound of Formula 7a (259.9 mg,
0.80 mM) in methanol (4.5 ml) was added with potassium carbonate (275 mg, 1.99 mM) at room temperature, the temperature was raised to 40 ° C, and the mixture was stirred for 1 hour. The solvent of this reaction solution was evaporated under reduced pressure, 10 ml of saturated saline was added, and the mixture was extracted twice with 70 ml of ether. The combined organic layers were dried over magnesium sulfate, and the solvent was evaporated under reduced pressure. The residue was subjected to silica gel column chromatography, and 196.5 mg (yield 97%) of a colorless oily compound represented by the formula 7b from a fraction of ether / n-hexane (1: 2).
I got
【0043】また、式7b化合物合成の別法として次の
方法により合成した。式6bの化合物( 1.24g, 3.26m
M)のメタノール(40ml)溶液に活性化した亜鉛( 640m
g, 9.79mM)と酢酸( 1ml)を順次室温で加え、40℃に
昇温して超音波に1時間付した。この反応液をエーテル
200mlで希釈した後セライト濾過し、その濾液を5 %塩
酸水溶液30ml、飽和炭酸水素ナトリウム水溶液30ml、飽
和食塩水30mlで順次洗浄し、硫酸マグネシウムで乾燥し
た後減圧下で溶媒を留去した。残渣をシリカゲルクロマ
トグラフィーに付し、エーテル/n−ヘキサン(1:
2)の留分から無色油状の式7bで表される化合物 720
mg(収率87%)を得た。式7bの化合物のスペクトルデ
ータおよび元素分析結果は以下の通りである。As another method for synthesizing the compound of formula 7b, it was synthesized by the following method. Compound of formula 6b (1.24g, 3.26m
M) in methanol (40ml) solution activated zinc (640m
g, 9.79 mM) and acetic acid (1 ml) were sequentially added at room temperature, the temperature was raised to 40 ° C., and ultrasonication was performed for 1 hour. This reaction solution is ether
The mixture was diluted with 200 ml and filtered through Celite, and the filtrate was washed successively with 30 ml of 5% hydrochloric acid aqueous solution, 30 ml of saturated sodium hydrogen carbonate aqueous solution and 30 ml of saturated saline, dried over magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was chromatographed on silica gel with ether / n-hexane (1:
A compound of the formula 7b which is a colorless oil from the fraction of 2) 720
mg (yield 87%) was obtained. The spectral data and elemental analysis results of the compound of formula 7b are as follows.
【0044】 [α]D 27;−32.3°(C=1.15, クロロフォルム) IRνmax (neat)cm-1 ; 3446 , 3312 , 2954 , 2932 ,
2858 , 1256 , 1098, 837 , 774 。1 H−NMR (300MHz , CDCl3); δ5.89(ddd, 1H, J=5.
5, 10.3, 16.9Hz), 5.27( dt, 1H, J=17.2, 1.1Hz),
5.10( dt, 1H, J=10.3, 1.5Hz), 4.47〜4.37( m, 1
H), 4.21〜4.10( m, 1H), 2.72(d, 1H, J=3.3Hz),
2. 45(dd, 2H,J=2.9, 6.6Hz), 2.01(t, 1H, J=2.8H
z), 1.90〜1.72( m, 2H), 0.90( s,9H), 0.12(
s, 6H)。 MS ;255 (M+ +H+ ), 197(M+ −C4H9), 75( 1
00%)。 Anal. Calcd. for C14H26O2Si ,C ; 66.09 , H ; 10.3
0 。 Found: C ; 65.83 , H ; 10.43。[Α] D 27 ; −32.3 ° (C = 1.15, chloroform) IRνmax (neat) cm −1 ; 3446, 3312, 2954, 2932,
2858, 1256, 1098, 837, 774. 1 H-NMR (300 MHz, CDCl 3 ); δ5.89 (ddd, 1H, J = 5.
5, 10.3, 16.9Hz), 5.27 (dt, 1H, J = 17.2, 1.1Hz),
5.10 (dt, 1H, J = 10.3, 1.5Hz), 4.47 ~ 4.37 (m, 1
H), 4.21 to 4.10 (m, 1H), 2.72 (d, 1H, J = 3.3Hz),
2.45 (dd, 2H, J = 2.9, 6.6Hz), 2.01 (t, 1H, J = 2.8H
z), 1.90 to 1.72 (m, 2H), 0.90 (s, 9H), 0.12 (
s, 6H). MS; 255 (M + + H + ), 197 (M + −C 4 H 9 ), 75 (1
00%). Anal. Calcd. For C 14 H 26 O 2 Si, C; 66.09, H; 10.3
0. Found: C; 65.83, H; 10.43.
【0045】実施例13 <式7cの化合物の合成>式7bの化合物( 164.6mg,
0.65mM)のジメチルフォルムアミド( 2ml)溶液にイミ
ダゾール( 168mg, 2.46mM)、触媒量の4−ジメチルア
ミノピリジン、t−ブチルジメチルシリルクロライド
( 156mg, 1.04mM)を順次加え、室温で12時間攪拌し
た。この反応液に水 5mlを加え、エーテル40mlで2回抽
出した。合わせた有機層を飽和食塩水 5mlで洗浄し、硫
酸マグネシウムで乾燥し、減圧下溶媒留去した。残渣を
シリカゲルカラムクロマトグラフィーに付し、エーテル
/n−ヘキサン(1:30)の留分から無色油状の式7c
で表される化合物 224.9mg(収率94%)を得た。式7c
の化合物のスペクトルデータおよび元素分析結果は以下
の通りである。Example 13 <Synthesis of Compound of Formula 7c> Compound of Formula 7b (164.6 mg,
0.65mM) in dimethylformamide (2ml) was added with imidazole (168mg, 2.46mM), catalytic amount of 4-dimethylaminopyridine and t-butyldimethylsilyl chloride (156mg, 1.04mM), and stirred for 12 hours at room temperature. did. 5 ml of water was added to this reaction solution, and the mixture was extracted twice with 40 ml of ether. The combined organic layers were washed with 5 ml of saturated brine, dried over magnesium sulfate, and the solvent was evaporated under reduced pressure. The residue was subjected to silica gel column chromatography to obtain a colorless oily compound of formula 7c from a fraction of ether / n-hexane (1:30).
224.9 mg (yield 94%) of the compound represented by was obtained. Formula 7c
The spectral data and elemental analysis results of the compound are as follows.
【0046】 [α]D 30;−10.3°(C=1.50, クロロフォルム) IRνmax (neat)cm-1 ; 3316 , 2956 , 2932 , 2890 ,
2858 , 1254 , 1091, 835 , 772 。1 H−NMR (300MHz , CDCl3); δ5.82(ddd, 1H, J=7.
3, 10.3, 17.3Hz), 5.14(bd, 1H, J=16.9Hz), 5.04
(bd, 1H, J=10.3Hz), 4.22(dt, 1H, J=5.5, 7.0H
z), 3.98〜3.88( m, 1H), 2.40〜2.32( m, 2H),
1.98(t, 1H, J=2.4Hz), 1.88( ddd, 1H, J=5.1, 7.
3, 13.2Hz), 1.65( ddd, 1H, J=5.1, 6.2, 13.6Hz),
0.89(s, 18H), 0.09( s, 6H), 0.06( s, 3H),
0.04( s, 3H)。 MS ; 311(M+ −C4H9), 171( 100%), 73( 100
%)。 Anal. Calcd. for C20H40O2Si2 ,C ; 65.17 , H ; 1
0.95 。 Found: C ; 64.99 , H ; 10.93。[Α] D 30 ; −10.3 ° (C = 1.50, chloroform) IRνmax (neat) cm −1 ; 3316, 2956, 2932, 2890,
2858, 1254, 1091, 835, 772. 1 H-NMR (300 MHz, CDCl 3 ); δ5.82 (ddd, 1H, J = 7.
3, 10.3, 17.3Hz), 5.14 (bd, 1H, J = 16.9Hz), 5.04
(Bd, 1H, J = 10.3Hz), 4.22 (dt, 1H, J = 5.5, 7.0H
z), 3.98 ~ 3.88 (m, 1H), 2.40 ~ 2.32 (m, 2H),
1.98 (t, 1H, J = 2.4Hz), 1.88 (ddd, 1H, J = 5.1, 7.
3, 13.2Hz), 1.65 (ddd, 1H, J = 5.1, 6.2, 13.6Hz),
0.89 (s, 18H), 0.09 (s, 6H), 0.06 (s, 3H),
0.04 (s, 3H). MS; 311 (M + −C 4 H 9 ), 171 (100%), 73 (100
%). Anal. Calcd. For C 20 H 40 O 2 Si 2 , C; 65.17, H; 1
0.95. Found: C; 64.99, H; 10.93.
【0047】実施例14 <式8aの化合物の合成>式7cの化合物( 202mg, 0.
55mM)のテトラヒドロフラン(4ml)溶液に−78℃で1.
4M n−ブチルリチウム/n−ヘキサン溶液(0.47ml,
0.66mM)を徐々に滴下し、40分間同温度で攪拌した。−
78℃でこの反応液にクロル炭酸メチル(0.08ml, 0.77m
M)を徐々に滴下し、2時間攪拌した。この反応液を0
℃まで昇温して飽和塩化アンモニウム水溶液1mlを加え
て20分間攪拌して室温まで昇温した。この反応液に水10
mlを加え、エーテル70mlで2回抽出後、有機層を合わ
せ、飽和食塩水10mlで洗浄し、硫酸マグネシウムで乾燥
し、減圧下溶媒留去した。残渣をシリカゲルカラムクロ
マトグラフィーに付し、エーテル/n−ヘキサン(1:
80)の留分から無色油状の式8aで表される化合物 18
1.2mg(収率78%)を得た。式8aの化合物のスペクト
ルデータおよび元素分析結果は以下の通りである。Example 14 <Synthesis of Compound of Formula 8a> Compound of Formula 7c (202 mg, 0.
55 mM) in tetrahydrofuran (4 ml) at -78 ° C 1.
4M n-butyllithium / n-hexane solution (0.47 ml,
0.66 mM) was gradually added dropwise, and the mixture was stirred at the same temperature for 40 minutes. −
Methyl chlorocarbonate (0.08ml, 0.77m)
M) was gradually added dropwise, and the mixture was stirred for 2 hours. This reaction solution is
The temperature was raised to 0 ° C., 1 ml of a saturated aqueous ammonium chloride solution was added, and the mixture was stirred for 20 minutes and warmed to room temperature. Water 10
ml was added, the mixture was extracted twice with 70 ml of ether, the organic layers were combined, washed with 10 ml of saturated saline, dried over magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was subjected to silica gel column chromatography, and ether / n-hexane (1:
A colorless oily compound of the formula 8a
1.2 mg (yield 78%) was obtained. The spectral data and elemental analysis results of the compound of formula 8a are as follows.
【0048】 [α]D 28;− 4.7°( C=1.145, クロロフォルム) IRνmax (neat)cm-1 ; 2954 , 2932 , 2890 , 2858 ,
2240 , 1721 , 1255, 1077 , 837 , 773。1 H−NMR (300MHz , CDCl3); δ5.80(ddd, 1H, J=7.
3, 10.3, 17.2Hz), 5.14(bd, 1H, J=17.2Hz), 5.05
(bd, 1H, J=10.3Hz), 4.21(dt, 1H, J=5.5, 7.0H
z), 4.07〜3.92( m, 1H), 3.75( m, 3H), 2.56(
dd, 1H, J=5.5, 16.8Hz), 2.46( dd, 1H, J=5.5, 17.
2Hz), 1.82( ddd, 1H, J=5.9, 7.3, 13.2Hz), 1.70
( dt, 1H, J=13.9, 5.5Hz), 0.89(s, 18H), 0.10
( s, 3H), 0.09( s, 3H), 0.06( s, 3H), 0.04
( s, 3H)。 MS ; 411(M+ −15), 369 (M+ −57), 171 (100
%), 147 (M+ − 279), 73(100 %)。 Anal. Calcd. for C22H42O4Si2, C ; 61.93 , H ; 9.
93。 Found: C ; 61.79 , H ; 10.03。[Α] D 28 ; −4.7 ° (C = 1.145, chloroform) IRνmax (neat) cm −1 ; 2954, 2932, 2890, 2858,
2240, 1721, 1255, 1077, 837, 773. 1 H-NMR (300 MHz, CDCl 3 ); δ5.80 (ddd, 1H, J = 7.
3, 10.3, 17.2Hz), 5.14 (bd, 1H, J = 17.2Hz), 5.05
(Bd, 1H, J = 10.3Hz), 4.21 (dt, 1H, J = 5.5, 7.0H
z), 4.07 to 3.92 (m, 1H), 3.75 (m, 3H), 2.56 (
dd, 1H, J = 5.5, 16.8Hz), 2.46 (dd, 1H, J = 5.5, 17.
2Hz), 1.82 (ddd, 1H, J = 5.9, 7.3, 13.2Hz), 1.70
(Dt, 1H, J = 13.9, 5.5Hz), 0.89 (s, 18H), 0.10
(S, 3H), 0.09 (s, 3H), 0.06 (s, 3H), 0.04
(S, 3H). MS; 411 (M + −15), 369 (M + −57), 171 (100
%), 147 (M + -279), 73 (100%). Anal. Calcd. For C 22 H 42 O 4 Si 2 , C; 61.93, H; 9.
93. Found: C; 61.79, H; 10.03.
【0049】実施例 15 <式8bの化合物の合成>式7cの化合物( 500mg, 1.
36mM)のテトラヒドロフラン(10ml)溶液に−78℃で1.
4M n−ブチルリチウム/n−ヘキサン溶液( 1.2ml,
1.63mM)を徐々に滴下し、40分間同温度で攪拌した。−
78℃でこの反応液にクロル炭酸エチル( 0.2ml, 1.90m
M)を徐々に滴下し、 2.5時間攪拌した。この反応液を
0℃まで昇温して飽和塩化アンモニウム水溶液 2mlを加
えて20分間攪拌して室温まで昇温した。この反応液に水
20mlを加え、エーテル 150mlで 2回抽出後、有機層を合
わせ、飽和食塩水20mlで洗浄し、硫酸マグネシウムで乾
燥し、減圧下溶媒留去した。残渣をシリカゲルカラムク
ロマトグラフィーに付し、エーテル/n−ヘキサン
(1:30)の留分から無色油状の式8bで表される化合
物 482.1mg(収率81%)を得た。式8bの化合物のスペ
クトルデータおよび元素分析結果は以下の通りである。Example 15 <Synthesis of Compound of Formula 8b> Compound of Formula 7c (500 mg, 1.
36 mM) in tetrahydrofuran (10 ml) at -78 ° C 1.
4M n-butyllithium / n-hexane solution (1.2 ml,
1.63 mM) was gradually added dropwise, and the mixture was stirred at the same temperature for 40 minutes. −
Ethyl chlorocarbonate (0.2 ml, 1.90 m
M) was gradually added dropwise, and the mixture was stirred for 2.5 hours. The temperature of this reaction solution was raised to 0 ° C., 2 ml of a saturated aqueous solution of ammonium chloride was added, and the mixture was stirred for 20 minutes and warmed to room temperature. Water in this reaction solution
After adding 20 ml and extracting twice with 150 ml of ether, the organic layers were combined, washed with 20 ml of saturated saline, dried over magnesium sulfate, and the solvent was distilled off under reduced pressure. The residue was subjected to silica gel column chromatography to obtain 482.1 mg (yield 81%) of a compound represented by the formula 8b as a colorless oil from a fraction of ether / n-hexane (1:30). The spectral data and elemental analysis results of the compound of formula 8b are as follows.
【0050】 [α]D 25;− 3.5°(C=1.23, クロロフォルム) IRνmax (neat)cm-1 ; 2956 , 2932 , 2856 , 2236 ,
1715 , 1252 , 1073, 836 , 773 。1 H−NMR (300MHz , CDCl3); δ5.80(ddd, 1H, J=7.
3, 10.3, 17.2Hz), 5.14(bd, 1H, J=17.2Hz), 5.05
(bd, 1H, J=10.3Hz), 4.24〜4.17( m, 3H),3.98(
dt, 1H, J=5.9, 11.7Hz), 2.56( dd, 1H, J=5.5, 16.
9Hz), 2.46( dd, 1H, J=5.9, 17.2Hz), 1.82( ddd,
1H, J=5.9, 7.3, 13.2Hz), 1.70( dt,1H, J=13.9,
5.5Hz), 1.30(t, 3H, J=7.1Hz), 0.89(s, 18H),
0.10( s,3H), 0.09( s, 3H), 0.06( s, 3H), 0.0
4( s, 3H)。 MS ; 425(M+ −15), 383 (M+ −57), 171( 100
%),147(M− 279),73( 100%)。 Anal. Calcd. for C23H44O4Si2, C ; 62.67 , H ; 1
0.06 。 Found: C ; 62.70 , H ; 10.06。[Α] D 25 ; −3.5 ° (C = 1.23, chloroform) IRνmax (neat) cm −1 ; 2956, 2932, 2856, 2236,
1715, 1252, 1073, 836, 773. 1 H-NMR (300 MHz, CDCl 3 ); δ5.80 (ddd, 1H, J = 7.
3, 10.3, 17.2Hz), 5.14 (bd, 1H, J = 17.2Hz), 5.05
(Bd, 1H, J = 10.3Hz), 4.24 ~ 4.17 (m, 3H), 3.98 (
dt, 1H, J = 5.9, 11.7Hz), 2.56 (dd, 1H, J = 5.5, 16.
9Hz), 2.46 (dd, 1H, J = 5.9, 17.2Hz), 1.82 (ddd,
1H, J = 5.9, 7.3, 13.2Hz), 1.70 (dt, 1H, J = 13.9,
5.5Hz), 1.30 (t, 3H, J = 7.1Hz), 0.89 (s, 18H),
0.10 (s, 3H), 0.09 (s, 3H), 0.06 (s, 3H), 0.0
4 (s, 3H). MS; 425 (M + −15), 383 (M + −57), 171 (100
%), 147 (M-279), 73 (100%). Anal. Calcd. For C 23 H 44 O 4 Si 2 , C; 62.67, H; 1
0.06. Found: C; 62.70, H; 10.06.
【0051】実施例16 <式9aの化合物の合成>式8aの化合物(35mg, 82.2
μ )のベンゼン( 2ml)溶液に亜リン酸トリメチル
( 8.3μl,70.4μ ),Pd2(dba )3 ・CHCl3 (17mg,
16.4μM 、dbaはジベンジリデンアセトンの略称であ
る。以下の例に於ても同じ。), 酢酸(1μl ,1.7μM
)を室温で順次加え、同温度で12時間、窒素雰囲気下
で攪拌した。この溶媒留去後、残渣をシリカゲルカラム
クロマトグラフィーに付し、エーテル/n−ヘキサン
(1:20)の留分から無色油状の式9aで表される化合
物22.3mg(収率64%)を得た。式9aの化合物のスペク
トルデータおよび元素分析結果は以下の通りである。Example 16 <Synthesis of Compound of Formula 9a> Compound of Formula 8a (35 mg, 82.2
μ) in benzene (2 ml), trimethyl phosphite (8.3 μl, 70.4 μ), Pd 2 (dba) 3 · CHCl 3 (17 mg,
16.4 μM, dba is an abbreviation for dibenzylideneacetone. The same applies to the following examples. ), Acetic acid (1 μl, 1.7 μM
) Was sequentially added at room temperature, and the mixture was stirred at the same temperature for 12 hours under a nitrogen atmosphere. After distilling off the solvent, the residue was subjected to silica gel column chromatography to obtain 22.3 mg (yield 64%) of a compound represented by the formula 9a as colorless oil from a fraction of ether / n-hexane (1:20). . The spectral data and elemental analysis results of the compound of formula 9a are as follows.
【0052】IRνmax (neat)cm-1 ; 2930 , 2856 , 1
721 , 1642 , 1471 。1 H−NMR (500MHz , CDCl3); δ5.89( s, 1H), 5.07
(bs, 1H), 5.05(bs, 1H), 4.58〜4.53( m, 1H),
4.27〜4.19( m, 1H), 3.68( s, 3H), 3.33( dd, 1
H, J=5.2, 14.7Hz), 2.67(bd, 1H, J=14.7Hz), 1.98
〜1.89( m, 1H), 1.80〜1.70( m, 1H)0.88( s, 9
H), 0.84( s, 9H), 0.04(s, 12H)。13 C−NMR (125MHz , CDCl3); δ 167.02 , 157.48 ,
152.08 , 116.06 , 109.96 , 70.22 , 67.14 , 51.07
, 43.73 , 37.58 , 25.87 , 25.76 , 18.31 ,18.12 ,
−4.93 ,−5.00。 MS ; 411(M+ −15), 395 (M+ −31), 369 (M+
−57), 73( 100%)。IR ν max (neat) cm -1 ; 2930, 2856, 1
721, 1642, 1471. 1 H-NMR (500 MHz, CDCl 3 ); δ5.89 (s, 1H), 5.07
(Bs, 1H), 5.05 (bs, 1H), 4.58 ~ 4.53 (m, 1H),
4.27 ~ 4.19 (m, 1H), 3.68 (s, 3H), 3.33 (dd, 1
H, J = 5.2, 14.7Hz), 2.67 (bd, 1H, J = 14.7Hz), 1.98
~ 1.89 (m, 1H), 1.80 ~ 1.70 (m, 1H) 0.88 (s, 9
H), 0.84 (s, 9H), 0.04 (s, 12H). 13 C-NMR (125 MHz, CDCl 3 ); δ 167.02, 157.48,
152.08, 116.06, 109.96, 70.22, 67.14, 51.07
, 43.73, 37.58, 25.87, 25.76, 18.31, 18.12,
−4.93, −5.00. MS; 411 (M + −15), 395 (M + −31), 369 (M +
-57), 73 (100%).
【0053】実施例17 <式9bの化合物の合成>式8bの化合物(30mg, 68.2
μM )のベンゼン( 2ml)溶液にエチレンビス(ジフェ
ニルフォスフィン(2.7mg, 6.8μM ), Pd2 (dba )3
・CHCl3 (14mg,13.5μM ), ピバリン酸( 4μl , 34.
1μM )を室温で順次加え、50℃に昇温して15時間、窒
素雰囲気下で攪拌した。溶媒留去後、残渣をシリカゲル
カラムクロマトグラフィーに付し、エーテル/n−ヘキ
サン( 1:20)の留分から無色油状の式9bで表される
化合物21.1mg(収率69%)を得た。式9bの化合物のス
ペクトルデータは以下の通りである。Example 17 <Synthesis of Compound of Formula 9b> Compound of Formula 8b (30 mg, 68.2
solution of ethylene bis (diphenylphosphine (2.7mg, 6.8μM), Pd 2 (dba) 3 in benzene (2ml)
・ CHCl 3 (14 mg, 13.5 μM), pivalic acid (4 μl, 34.
1 μM) was sequentially added at room temperature, the temperature was raised to 50 ° C., and the mixture was stirred for 15 hours under a nitrogen atmosphere. After distilling off the solvent, the residue was subjected to silica gel column chromatography to obtain 21.1 mg (yield 69%) of a colorless oily compound of the formula 9b from a fraction of ether / n-hexane (1:20). The spectral data of the compound of formula 9b is as follows.
【0054】1H−NMR (300MHz , CDCl3); δ5.89( b
rs, 1H), 5.07(t, 1H, J=1.8Hz), 5.06(t, 1H, J=
1.8Hz), 4.57〜4.54( m, 1H), 4.26〜4.22( m, 1
H), 4.18〜4.10( m, 2H), 3.36( dd, 1H, J=5.5, 1
4.7Hz), 2.64( dt, 1H, J=2.4, 14.7Hz), 1.97〜1.9
2( m, 1H), 1.75(ddd, 1H, J= 1.8, 9.2, 11.6Hz),
1.26(t, 3H, J=7.3Hz), 0.85( s, 9H), 0.04(s, 1
2H)。 1 H-NMR (300 MHz, CDCl 3 ); δ 5.89 (b
rs, 1H), 5.07 (t, 1H, J = 1.8Hz), 5.06 (t, 1H, J =
1.8Hz), 4.57 ~ 4.54 (m, 1H), 4.26 ~ 4.22 (m, 1
H), 4.18 ~ 4.10 (m, 2H), 3.36 (dd, 1H, J = 5.5, 1
4.7Hz), 2.64 (dt, 1H, J = 2.4, 14.7Hz), 1.97 to 1.9
2 (m, 1H), 1.75 (ddd, 1H, J = 1.8, 9.2, 11.6Hz),
1.26 (t, 3H, J = 7.3Hz), 0.85 (s, 9H), 0.04 (s, 1
2H).
【0055】[0055]
【発明の効果】本発明は、骨粗髪症その他の疾病に対す
る治療薬カルシトリオール及びその関連のビタミン誘導
体を製造する際のA環部に相当する重要中間体を効率よ
く簡単な反応経路で得ることのできる原料化合物として
重要である。INDUSTRIAL APPLICABILITY The present invention efficiently and easily obtains an important intermediate corresponding to the A ring portion in the production of calcitriol and its related vitamin derivative for the treatment of osteoporosis and other diseases by a simple reaction route. It is important as a raw material compound.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 C07F 7/18 S W // C07D 303/20 ─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification code Office reference number FI technical display location C07F 7/18 SW // C07D 303/20
Claims (4)
シ−オクタ−2,7−ジイン−1−オール及びそのシリ
ル誘導体。 【化1】 (但しR1 は水素もしくはトリメチルシリル基を,R2
は水素もしくはt−ブチルジメチルシリル基を, R3 は
テトラヒドロピラニル基もしくは水素を表す。)1. A compound of formula 1, S-5-hydroxy-octa-2,7-diyn-1-ol and silyl derivatives thereof. Embedded image (However, R 1 is hydrogen or trimethylsilyl group, R 2
Represents hydrogen or a t-butyldimethylsilyl group, and R 3 represents a tetrahydropyranyl group or hydrogen. )
が水素及びR3 がテトラヒドロピラニル基である請求項
1記載の化合物。2. R 1 of the formula 1 is a trimethylsilyl group, R 2
The compound according to claim 1, wherein is hydrogen and R 3 is a tetrahydropyranyl group.
ルシリル−1,2−オキシラニルペンタ−4−インをプ
ロパルギルテトラヒドロピラニルエーテルおよびn−ブ
チルリチウムと反応させることを特徴とする請求項2記
載の化合物の製法。 【化2】 (但し、TMS はトリメチルシリル基を表す)3. The compound of formula 2, S-5-trimethylsilyl-1,2-oxiranylpent-4-yne, is reacted with propargyl tetrahydropyranyl ether and n-butyllithium. 2. A method for producing the compound according to 2. Embedded image (However, TMS represents a trimethylsilyl group)
シラニルヘキサ−2−イニルテトラヒドロピラニルエー
テルをトリメチルシリルアセチレン、n−ブチルリチウ
ムと反応させることを特徴とする請求項2記載の化合物
の製法。 【化3】 (但し、THP はテトラヒドロピラニル基を表す)4. The compound R-5,6-oxiranylhex-2-ynyltetrahydropyranyl ether represented by the formula 3 is reacted with trimethylsilylacetylene and n-butyllithium. Of the compound of. [Chemical 3] (However, THP represents a tetrahydropyranyl group)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21394494A JP2929943B2 (en) | 1994-09-07 | 1994-09-07 | Calcitriol intermediate and process for producing the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP21394494A JP2929943B2 (en) | 1994-09-07 | 1994-09-07 | Calcitriol intermediate and process for producing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0873390A true JPH0873390A (en) | 1996-03-19 |
| JP2929943B2 JP2929943B2 (en) | 1999-08-03 |
Family
ID=16647640
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP21394494A Expired - Fee Related JP2929943B2 (en) | 1994-09-07 | 1994-09-07 | Calcitriol intermediate and process for producing the same |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2929943B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011520950A (en) * | 2008-05-20 | 2011-07-21 | フイルメニツヒ ソシエテ アノニム | Process for producing β-santalol and its derivatives |
-
1994
- 1994-09-07 JP JP21394494A patent/JP2929943B2/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011520950A (en) * | 2008-05-20 | 2011-07-21 | フイルメニツヒ ソシエテ アノニム | Process for producing β-santalol and its derivatives |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2929943B2 (en) | 1999-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Grieco et al. | Dianions of. beta.-ketophosphonates. Two-step synthesis of (+)-ar-turmerone | |
| CN100406451C (en) | Method for preparing prostaglandin derivatives and raw materials thereof | |
| US5677467A (en) | Synthesis of acetogenins | |
| US4233231A (en) | Novel vinyl-stannyl derivatives | |
| JP2929943B2 (en) | Calcitriol intermediate and process for producing the same | |
| Srinivas et al. | Stereoselective total synthesis of (+)-varitriol | |
| Bates et al. | Total synthesis of the cholesterol biosynthesis inhibitor 1233A via a (π-allyl) tricarbonyliron lactone complex | |
| JP2000143688A (en) | Production of zeaxanthin mono-beta-glucoside | |
| JP2756608B2 (en) | Method for producing optically active isoxazole derivative, intermediate for producing the same, and method for producing the same | |
| JP2654835B2 (en) | Optically active 4-en-6-ol compounds, intermediates for their production and methods for their production | |
| JP2654834B2 (en) | Optically active vinyl compound, intermediate for producing the same, and method for producing them | |
| Varanchuk et al. | Allylation of (R)-2, 3-O-Cyclohexylideneglyceraldehyde with 2-Substituted Allylstannanes. Application in the Synthesis of Natural Compounds | |
| Meshram et al. | Total synthesis of nonenolide | |
| JPS61126048A (en) | Production of optically active 4-hydroxy-2-cyclopentenone | |
| WO2025045913A1 (en) | Processes for making amberketal from silylated hydroxyfarnesylacetonate | |
| US4477388A (en) | Vinylstannyl derivatives | |
| JP3883263B2 (en) | Asymmetric synthesis of macrocarpals | |
| JP2503040B2 (en) | α-Substituted-γ-alkoxyallyl sulfide derivative and method for producing the same | |
| JPH04321641A (en) | Production of terpene alpha-ketols | |
| JPH04305548A (en) | Halogeno allyl alcohol derivative | |
| JPH08134070A (en) | New synthesis of 15-hydroxymilbemycin derivative | |
| Cortez | Ga (III)-Catalyzed Cycloisomerization Approach to the Icetexones and Nominine | |
| WO1991008187A1 (en) | Open-chain terpene compound | |
| Zhu | Application of a novel carbonyl ene reaction: Total syntheses of phyllanthocin and chlorovulone II | |
| JPH0651694B2 (en) | Optically active compound |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090521 Year of fee payment: 10 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 10 Free format text: PAYMENT UNTIL: 20090521 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 11 Free format text: PAYMENT UNTIL: 20100521 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 11 Free format text: PAYMENT UNTIL: 20100521 |
|
| FPAY | Renewal fee payment (prs date is renewal date of database) |
Year of fee payment: 12 Free format text: PAYMENT UNTIL: 20110521 |
|
| LAPS | Cancellation because of no payment of annual fees |